<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title>Frontiers in Nutrition</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Nutr.</abbrev-journal-title>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnut.2023.1226107</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Nutrition</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Oxidative balance score inversely associated with the prevalence and incidence of metabolic syndrome: analysis of two studies of the Korean population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Hye-Min</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Tea-Hwa</given-names>
</name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kwon</surname>
<given-names>Yu-Jin</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1626269/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lee</surname>
<given-names>Jun-Hyuk</given-names>
</name>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
<xref rid="aff5" ref-type="aff"><sup>5</sup></xref>
<xref rid="c002" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1664500/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Primary Care Research Center, National Health Insurance Service Ilsan Hospital</institution>, <addr-line>Goyang</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff2"><sup>2</sup><institution>Health-IT Center, Yonsei University Severance Hospital</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Family Medicine, Yongin Severance Hospital, Yonsei University College of Medicine</institution>, <addr-line>Yongin</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Family Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Medicine, Hanyang University School of Medicine</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001"><p>Edited by: Karolina Skonieczna-&#x017B;ydecka, Pomeranian Medical University, Poland</p></fn>
<fn fn-type="edited-by" id="fn0002"><p>Reviewed by: Miguel Murgu&#x00ED;a-Romero, National Autonomous University of Mexico, Mexico; Xin Chen, Tongji University, China; Yingqian Zhu, Tongji University, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Yu-Jin Kwon, <email>digda3@yuhs.ac</email></corresp>
<corresp id="c002">Jun-Hyuk Lee, <email>swpapa@eulji.ac.kr</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>10</volume>
<elocation-id>1226107</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>05</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>08</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Park, Han, Kwon and Lee.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Park, Han, Kwon and Lee</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Pro-oxidant/antioxidant imbalances leading to chronic inflammation and insulin resistance can contribute to the development of metabolic syndrome (MetS). Oxidative Balance Score (OBS), a comprehensive measure of exposure to pro- and anti-oxidants, represents an individual&#x2019;s total oxidative balance. This study aimed to evaluate the association between OBS and MetS using two large datasets.</p>
</sec>
<sec>
<title>Methods</title>
<p>We analyzed data from 2,735 adults older than 19&#x2009;years from the 2021 Korean National Health and Nutritional Examination Survey (KNHANES) and 5,807 adults aged 40&#x2013;69&#x2009;years from the Korean Genome and Epidemiology Study (KoGES). In each dataset, OBS was categorized into sex-specific tertiles (T).</p>
</sec>
<sec>
<title>Results</title>
<p>In KNHANES, the odds ratios and 95% confidence intervals for prevalent MetS in T3, compared to T1, were 0.44 (0.29&#x2013;0.65) in men and 0.34 (0.23&#x2013;0.50) in women after adjusting for confounders. In KoGES, the hazard ratios and 95% confidence intervals for incident MetS in T3, compared to T1, were 0.56 (0.48&#x2013;0.65) in men and 0.63 (0.55&#x2013;0.73) in women after adjusting for confounders.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>OBS appears to be inversely related to MetS, which suggests that adopting lifestyle behaviors that decrease oxidative stress could be an important preventive strategy for MetS.</p>
</sec>
</abstract>
<kwd-group>
<kwd>oxidative balance score</kwd>
<kwd>pro-oxidant</kwd>
<kwd>antioxidant</kwd>
<kwd>metabolic syndrome</kwd>
<kwd>Korean Genome and Epidemiology Study</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="49"/>
<page-count count="11"/>
<word-count count="8094"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Clinical Nutrition</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1.</label>
<title>Introduction</title>
<p>Metabolic syndrome (MetS) is a cluster of metabolic dysregulations that place individuals at higher risk of type 2 diabetes and cardiovascular disease (<xref ref-type="bibr" rid="ref1">1</xref>). The global prevalence of MetS has been estimated to be around 25% (<xref ref-type="bibr" rid="ref2">2</xref>) and is continuously increasing in parallel with the prevalences of obesity and type 2 diabetes (<xref ref-type="bibr" rid="ref3">3</xref>). According to a meta-analysis of global data, the prevalence of MetS is higher in the Eastern Mediterranean Region (32.9, 95% CI: 28.7&#x2013;37.2) and the Americas (26.0, 95% CI: 22.7&#x2013;29.4) (<xref ref-type="bibr" rid="ref4">4</xref>). One report indicates that the prevalences of MetS in men and women in Korea in 2018 were 27.9 and 17.9%, respectively (<xref ref-type="bibr" rid="ref5">5</xref>). Additional research suggests that people with MetS spend 1.6 times more on health care than those without MetS ($5,732 vs. $3,581) (<xref ref-type="bibr" rid="ref6">6</xref>). Accordingly, public health experts should devote more attention to reducing the disease burden of MetS because it carries higher risks of cardiovascular mortality, all-cause mortality, and comorbidities, such as cerebrovascular disease, peripheral vascular disease, and cardiovascular disease, in addition to increased costs (<xref ref-type="bibr" rid="ref7">7</xref>).</p>
<p>Both insulin resistance and chronic systemic inflammation are key factors in MetS (<xref ref-type="bibr" rid="ref8">8</xref>). Emerging evidence demonstrates that systemic oxidant stress brought on by insulin resistance and excessive fatty acids activates a reciprocal interaction of downstream inflammatory pathways (<xref ref-type="bibr" rid="ref9">9</xref>). As such, interest in means with which to control oxidative stress and chronic inflammation in order to mitigate the severity of comorbid chronic diseases and to prevent MetS is growing (<xref ref-type="bibr" rid="ref10">10</xref>), and several studies have suggested that increasing consumption of dietary antioxidants and decreasing pro-inflammatory dietary behaviors can reduce oxidative stress levels and MetS incidence (<xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref12">12</xref>).</p>
<p>In the literature, researchers have highlighted differences in onset and progression of MetS between men and women. These differences can be attributed to various factors, including hormones, adipose tissue distribution, genetics, and lifestyle factors (<xref ref-type="bibr" rid="ref13">13</xref>). Oxidative balance score (OBS) is a useful tool for assessing an individual&#x2019;s oxidation&#x2013;reduction balance, including dietary and lifestyle factors (<xref ref-type="bibr" rid="ref14">14</xref>). Previous studies have suggested that combined measure of various pro-oxidants and anti-oxidants, including dietary and non-dietary factors, are closely associated with metabolic diseases (<xref ref-type="bibr" rid="ref14 ref15 ref16">14&#x2013;16</xref>). OBS could provide more comprehensive evaluation of oxidative stress and antioxidant capacity than individual markers alone. However, lack of standardized methodology for calculating OBS makes it difficult to compare scores across different populations or studies. Also, there is limited clinical utility for predicting disease risk (<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref17">17</xref>).</p>
<p>Although several studies have reported a relationship between OBS and MetS, results are inconsistent. A cross-sectional study conducted in Korea reported that OBS is inversely related to the risk of MetS in adults aged &#x2265;40&#x2009;years (<xref ref-type="bibr" rid="ref18">18</xref>), whereas an Iranian cross-sectional study did not show a significant association between OBS and MetS components (<xref ref-type="bibr" rid="ref19">19</xref>). Moreover, there is limited evidence of the association between OBS and the incidence of MetS from prospective cohort studies. Our study aimed to address a gap in current knowledge by investigating the association between OBS and MetS prevalence and incidence in two large, independent population-based datasets in a sex-specific manner.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<label>2.</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1.</label>
<title>Study population</title>
<p>This study utilized two population-based cohorts: the 2021 Korea National Health and Nutrition Examination Survey (KNHANES) and the Korean Genome and Epidemiology Study (KoGES). The KNHANES is a nationwide representative population-based survey. The cohort profile was described in detail in a previous study (<xref ref-type="bibr" rid="ref20">20</xref>). The 2021 KNHANES dataset included 7,090 participants aged 19&#x2009;years and older. The KoGES Ansan and Ansung study is a community-based prospective cohort study. The study design and procedures have been described in detail in a previous study (<xref ref-type="bibr" rid="ref21">21</xref>). The KoGES Ansan and Ansung cohort included 10,030 adults aged between 40 and 69&#x2009;years. This survey was first conducted in 2001 and 2002, and participants were followed up every 2&#x2009;years. In the present study, we included participants with up to eight follow-up evaluations conducted between 2017 and 2018.</p>
<p>A flowchart of the study population is provided in <xref rid="fig1" ref-type="fig">Figure 1</xref> (KNHANES and KoGES). Among the 7,090 participants in the 2021 KNHANES dataset, 2,735 participants (1,185 men and 1,550 women) were finally included for analysis after excluding participants who had missing data with which to evaluate MetS (<italic>n</italic>&#x2009;=&#x2009;1,197) and to calculate OBS (<italic>n</italic>&#x2009;=&#x2009;3,158). Among the 10,030 participants in the KoGES dataset, 5,807 participants (2,921 men and 2,886 women) were finally included for analysis after excluding participants with missing data needed for MetS evaluation (<italic>n</italic>&#x2009;=&#x2009;3), those with MetS at baseline (<italic>n</italic>&#x2009;=&#x2009;3,197), those who lacked data needed to calculate OBS (<italic>n</italic>&#x2009;=&#x2009;457), and those who did not participate in a follow-up after the baseline survey (<italic>n</italic>&#x2009;=&#x2009;566).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Flow chart of the study population.</p>
</caption>
<graphic xlink:href="fnut-10-1226107-g001.tif"/>
</fig>
<p>All participants in KNHANES and KOGES provided informed consent for data collection. The study protocol conformed to the ethical guidelines of the 1964 Declaration of Helsinki and its later amendments. This study was approved by the Institutional Review Board (IRB) of Nowon Eulji Medical Center (IRB number: 2021-09-025).</p>
</sec>
<sec id="sec4">
<label>2.2.</label>
<title>Oxidative balance score assessment</title>
<p>OBS was calculated from data on six pro-oxidant factors and five antioxidant factors selected based on previous studies (<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref22 ref23 ref24">22&#x2013;24</xref>), and data for all 11 factors were available in the both KHNANES and KoGES datasets. <xref rid="tab1" ref-type="table">Table 1</xref> presents the OBS assignment scheme. Pro-oxidant factors included saturated fatty acid (SFA), total iron intake, smoking status, drinking status, obesity status, and abdominal obesity status (<xref ref-type="bibr" rid="ref14">14</xref>, <xref ref-type="bibr" rid="ref25">25</xref>, <xref ref-type="bibr" rid="ref26">26</xref>). Each query was scored 0, 1, or 2, except for abdominal obesity status, which was scored 0 or 1. The scores for SFA and total iron intake were assigned 0&#x2013;2 points according to sex-specific tertile values (low, 2; intermediate, 1; high, 0) of each variable. The scores for never smokers, former smokers, and current smokers were 2, 1, and 0, respectively. The scores for non-drinkers, mild-to-moderate drinkers (1&#x2013;29&#x2009;g/day in men, 1&#x2013;19&#x2009;g/day in women), and heavy drinkers (&#x2265;30&#x2009;g/day in men, &#x2265;20&#x2009;g/day in women) were 2, 1, and 0, respectively. Obesity received 0 points, overweight received 1 point, and normal weight received 2 points. Zero points were given for abdominal obesity and 1 point for no abdominal obesity. Antioxidant factors included physical activity (high intensity, 2; moderate intensity, 1; low intensity, 0) and intake of omega-3 poly-unsaturated fatty acid (PUFA) to omega-6 PUFA ratio, vitamin C, vitamin E, and beta-carotene, which were each assigned 0&#x2013;2 points according to sex-specific tertile values (low, 0; intermediate, 1; high, 2) for each variable. Using OBS, which had a possible maximum of 21 points, we divided the individuals into tertile groups by sex. Higher OBS indicate higher antioxidant properties. In the KoGES and KNHANES datasets, OBS cut-off points were stratified into three categories: for men, T1 (&#x2266;11 for KoGES and &#x2266;10 for KNHANES), T2 (12&#x2013;13 for KoGES and 11&#x2013;12 for KNHANES), and T3 (&#x2267;14 for KoGES and &#x2267;13 for KNHANES); for women, T1 (&#x2266;12), T2 (13&#x2013;14), and T3 (&#x2267;15) in both datasets.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Oxidative balance score assignment scheme.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">OBS components</th>
<th align="left" valign="top">Assignment scheme<xref rid="tfn1" ref-type="table-fn"><sup>&#x002A;</sup></xref></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1. Saturated fatty acid [P]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;high (3rd tertile), 1&#x2009;=&#x2009;intermediate (2nd tertile), 2&#x2009;=&#x2009;low (1st tertile)</td>
</tr>
<tr>
<td align="left" valign="top">2. Total iron intake [P]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;high (3rd tertile), 1&#x2009;=&#x2009;intermediate (2nd tertile), 2&#x2009;=&#x2009;low (1st tertile)</td>
</tr>
<tr>
<td align="left" valign="top">3. Smoking status [P]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;current smoker, 1&#x2009;=&#x2009;former smoker, 2&#x2009;=&#x2009;never smoker</td>
</tr>
<tr>
<td align="left" valign="top">4. Drinking status [P]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;heavy drinker (&#x2265;30&#x2009;g/day in men, &#x2265;20&#x2009;g/day in women), 1&#x2009;=&#x2009;mild-to-moderate drinker (&#x003C;30&#x2009;g/day in men, &#x003C;20&#x2009;g/day in women), 2&#x2009;=&#x2009;non-drinker</td>
</tr>
<tr>
<td align="left" valign="top">5. Overweight/obese [P]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;obese, 1&#x2009;=&#x2009;overweight, 2&#x2009;=&#x2009;normal</td>
</tr>
<tr>
<td align="left" valign="top">6. Abdominal obesity [P]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;abdominal obesity, 1&#x2009;=&#x2009;normal</td>
</tr>
<tr>
<td align="left" valign="top">7. Omega-3/omega-6 PUFA ratio [A]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;low (1st tertile), 1&#x2009;=&#x2009;intermediate (2nd tertile), 2&#x2009;=&#x2009;high (3rd tertile)</td>
</tr>
<tr>
<td align="left" valign="top">8. Vitamin C intake [A]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;low (1st tertile), 1&#x2009;=&#x2009;intermediate (2nd tertile), 2&#x2009;=&#x2009;high (3rd tertile)</td>
</tr>
<tr>
<td align="left" valign="top">9. Vitamin E intake [A]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;low (1st tertile), 1&#x2009;=&#x2009;intermediate (2nd tertile), 2&#x2009;=&#x2009;high (3rd tertile)</td>
</tr>
<tr>
<td align="left" valign="top">10. Total beta-carotene intake [A]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;low (1st tertile), 1&#x2009;=&#x2009;intermediate (2nd tertile), 2&#x2009;=&#x2009;high (3rd tertile)</td>
</tr>
<tr>
<td align="left" valign="top">11. Physical activity [A]</td>
<td align="left" valign="top">0&#x2009;=&#x2009;low (&#x003C;7.5 METs-hr/day), 1&#x2009;=&#x2009;moderate (7.5&#x2013;30 METs-hr/day), 2&#x2009;=&#x2009;high (&#x003E;30 METs-hr/day)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1">
<label>&#x002A;</label>
<p>Low, intermediate, and high categories correspond to sex-specific tertile values among participants in the KoGES at the baseline survey or participants in the 2021 KNHANES. P, pro-oxidant; A, anti-oxidant; PUFA, poly-unsaturated fatty acid; MET, metabolic equivalent of task; KoGES, Korean Genome and Epidemiology Study; KNHANES, Korean National Health and Nutrition Examination Survey.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec5">
<label>2.3.</label>
<title>Definition of MetS</title>
<p>Based on the National Cholesterol Education Program Adult Treatment Panel III definition as amended by the National Heart Lung and Blood Institute and the American Heart Association (<xref ref-type="bibr" rid="ref27">27</xref>), we defined MetS as the presence of three or more of the following: (1) abdominal obesity as a waist circumference&#x2009;&#x2265;&#x2009;90&#x2009;cm in men and&#x2009;&#x2265;&#x2009;85&#x2009;cm in women based on the 2018 Korean Society for the Study of Obesity guidelines (<xref ref-type="bibr" rid="ref28">28</xref>); (2) fasting plasma glucose&#x2009;&#x2265;&#x2009;5.6&#x2009;mmol/L or use of oral hypoglycemic medication or insulin; (3) serum triglyceride concentration&#x2009;&#x2265;&#x2009;1.7&#x2009;mmol/L or use of lipid-lowering medication; (4) serum high-density lipoprotein (HDL) cholesterol concentration&#x2009;&#x003C;&#x2009;1.0&#x2009;mmol/L in men or&#x2009;&#x003C;&#x2009;1.3&#x2009;mmol/L in women; and (5) systolic blood pressure (SBP)&#x2009;&#x2265;&#x2009;130&#x2009;mmHg, diastolic blood pressure (DBP)&#x2009;&#x2265;&#x2009;85&#x2009;mmHg, or use of anti-hypertensive medication.</p>
</sec>
<sec id="sec6">
<label>2.4.</label>
<title>Covariates</title>
<p>Well-trained medical staff members performed the health examination sand health interviews following the KHANES protocol (<xref ref-type="bibr" rid="ref20">20</xref>) and KoGES protocol, respectively (<xref ref-type="bibr" rid="ref29">29</xref>). Body mass index (BMI) was calculated as a person&#x2019;s weight in kilograms divided by the square of their height in meters. Individuals with a BMI of at least 23&#x2009;kg/m<sup>2</sup> but less than 25&#x2009;kg/m<sup>2</sup> were considered overweight, and those with a BMI of &#x2265;25&#x2009;kg/m<sup>2</sup> were considered obese based on the 2018 Korean Society for the Study of Obesity guidelines (<xref ref-type="bibr" rid="ref28">28</xref>). Abdominal obesity was defined as a waist circumference&#x2009;&#x2265;&#x2009;90&#x2009;cm in men and&#x2009;&#x2265;&#x2009;85&#x2009;cm in women based on the same guidelines (<xref ref-type="bibr" rid="ref28">28</xref>). Mean blood pressure (MBP, mmHg) was calculated as DBP&#x2009;+&#x2009;1/3&#x2009;&#x00D7;&#x2009;(SBP &#x2013; DBP) (<xref ref-type="bibr" rid="ref30">30</xref>). Whole blood white blood count (WBC), plasma glucose, serum insulin, total cholesterol, triglycerides, HDL, cholesterol and C-reactive protein (CRP) were assessed using a Hitachi 700&#x2013;110 Chemistry Analyzer (Hitachi, Ltd., Tokyo, Japan) after at least 8&#x2009;h of fasting.</p>
<p>Information on smoking, alcohol consumption, physical activity, education level, and household income were obtained from self-reported questionnaires. A never smoker was defined as someone who had never smoked or had smoked fewer than 100 cigarettes in their lifetime. Former smokers were those who had quit smoking and had smoked more than 100 cigarettes during their lifetime. Current smokers were those who were active smokers at the time of the questionnaire and had smoked more than 100 cigarettes during their lifetime.</p>
<p>We further evaluated the daily alcohol intake (g/day) of each participant. Heavy drinkers were men who drank more than 30&#x2009;g/day and women who drank more than 20&#x2009;g/day. Mild-to-moderate drinkers were men who drank less than 30&#x2009;g/day and women who drank less than 20&#x2009;g/day. Non-drinkers were those who did not drink alcohol.</p>
<p>Physical activity was assessed using the metabolic equivalent of task&#x2013;hours per week (MET-hrs/day) using the International Physical Activity Questionnaire (<xref ref-type="bibr" rid="ref31">31</xref>). Participants were classified into low- (&#x003C;7.5 METs-hr/day), moderate- (7.5&#x2013;30 METs-hr/day), or high- (&#x003E;30 METs-hr/day) intensity physical activity groups. An in-person interview concerning nutrition was conducted in the respondent&#x2019;s home.</p>
<p>Total energy intake and nutritional status were calculated using a validated 112-item food frequency questionnaire (FFQ) developed for KNHANES (<xref ref-type="bibr" rid="ref32">32</xref>) and 103-item FFQ developed for KoGES (<xref ref-type="bibr" rid="ref33">33</xref>). Information for each item was collected based on recalls of the average frequency and amount consumed per serving over the past year. From the FFQ, this study considered the total daily intake values of energy (kcal/day), SFA (g/day), total iron (mg/day), omega-3 PUFA to omega-6 PUFA ratio, vitamin C (mg/day), vitamin E (mg/day), and beta-carotene (&#x03BC;g/day).</p>
<p>Participants were classified into elementary/middle school, high school, and college/university education levels. Monthly household income was divided into three groups: &#x003C;100 million Korean Won, 100&#x2013;200 million Korean Won, and&#x2009;&#x003E;&#x2009;200 million Korean Won.</p>
</sec>
<sec id="sec7">
<label>2.5.</label>
<title>Statistical analysis</title>
<p>We conducted a normality test, and variables with normal distribution are presented as means &#x00B1; standard deviations. Serum triglyceride, insulin, and CRP with non-normal distribution are presented as medians (25th percentile, 75th percentile). Continuous variables were compared using a one-way analysis of variance or the Kruskal&#x2013;Wallis test according to the sex-specific OBS tertiles. All statistical analyses were conducted separately for men and women. Categorical variables are described as numbers (%) and were compared using the chi-square test. The dose&#x2013;response relationship between OBS and the risk of incident MetS was determined using a Cox proportional hazard spline curve. Kaplan&#x2013;Meier curves with the log-rank test were used to verify the cumulative incidence of MetS according to the sex-specific OBS tertiles. For KNHANES, we calculated the odds ratio (OR) and 95% confidence intervals (CI) for the prevalence of MetS. For KoGES, we completed univariable and multivariable Cox proportional hazard regression analyses to calculate the HRs and 95% CIs for incident MetS of the second tertile (T2) and highest tertile (T3) groups, compared with the referent lowest tertile (T1) group, in a sex-specific manner. In the fully adjusted model, we adjusted for age, education level, monthly household income, total energy intake, MBP, WBC, fasting plasma glucose, and serum total cholesterol levels based on each population characteristics. Confounders were determined as variables influencing exposure and outcome based on a literature review and univariate analysis (<xref ref-type="bibr" rid="ref34">34</xref>, <xref ref-type="bibr" rid="ref35">35</xref>). We calculated variance inflation factor (VIF) values to assess the degree of multicollinearity among the variables, indicating that a VIF value of five or higher represents a high correlation of the variables (<xref ref-type="bibr" rid="ref36">36</xref>). In this study, the maximum VIF value observed was 2.1, which corresponded to the variable &#x2018;age&#x2019; in women (<xref rid="SM1" ref-type="supplementary-material">Supplementary Tables 1, 2</xref>). All statistical analyses were performed with SAS statistical software (version 9.4; SAS Institute Inc., Cary, NC, USA) and R software (version 4.1.1; R Foundation for Statistical Computing, Vienna, Austria). <italic>P</italic>-values less than 0.05 were regarded as statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="sec8">
<label>3.</label>
<title>Results</title>
<sec id="sec9">
<label>3.1.</label>
<title>Baseline characteristics of the study population</title>
<p><xref rid="tab2" ref-type="table">Table 2</xref> shows the baseline characteristics of the men according to OBS tertile in the KoGES and KNHANES, respectively. In the KoGES, the T3 group had lower fasting glucose, insulin, total cholesterol, triglyceride, and WBC. T3 men had higher intake of SFA, total iron, omega-3 to omega-6 PUFA ratio, vitamin C, vitamin E, and beta-carotene. Since we excluded participants with existing MetS at the baseline survey of KoGES, the proportion of participants with two MetS components was lowest in the T3 group.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Baseline characteristics of men in the KoGES and 2021 KNHANES.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top" colspan="8">Oxidative balance score tertiles</th>
</tr>
<tr>
<th/>
<th align="center" valign="top" colspan="3">Men in KoGES</th>
<th/>
<th align="center" valign="top" colspan="3">Men in KNHANES</th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Variables</td>
<td align="center" valign="top">T1 (<italic>n</italic> =&#x2009;1,128)</td>
<td align="center" valign="top">T2 (<italic>n</italic> =&#x2009;977)</td>
<td align="center" valign="top">T3 (<italic>n</italic> =&#x2009;816)</td>
<td align="center" valign="top"><italic>p</italic><xref rid="tfn2" ref-type="table-fn"><italic><sup>&#x002A;</sup></italic></xref></td>
<td align="center" valign="top">T1 (<italic>n</italic> =&#x2009;420)</td>
<td align="center" valign="top">T2 (<italic>n</italic> =&#x2009;310)</td>
<td align="center" valign="top">T3 (<italic>n</italic> =&#x2009;455)</td>
<td align="center" valign="top"><italic>p</italic><xref rid="tfn2" ref-type="table-fn"><italic><sup>&#x002A;</sup></italic></xref></td>
</tr>
<tr>
<td align="left" valign="top">Age, years</td>
<td align="center" valign="top">51.3&#x2009;&#x00B1;&#x2009;8.7</td>
<td align="center" valign="top">51.5&#x2009;&#x00B1;&#x2009;9.0</td>
<td align="center" valign="top">51.5&#x2009;&#x00B1;&#x2009;8.9</td>
<td align="center" valign="top">0.773</td>
<td align="center" valign="top">45.9&#x2009;&#x00B1;&#x2009;17.1</td>
<td align="center" valign="top">50.0&#x2009;&#x00B1;&#x2009;16.8</td>
<td align="center" valign="top">54.8&#x2009;&#x00B1;&#x2009;17.4</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">MBP, mmHg</td>
<td align="center" valign="top">95.3&#x2009;&#x00B1;&#x2009;11.6</td>
<td align="center" valign="top">95.6&#x2009;&#x00B1;&#x2009;12.1</td>
<td align="center" valign="top">95.1&#x2009;&#x00B1;&#x2009;12.5</td>
<td align="center" valign="top">0.657</td>
<td align="center" valign="top">93.2&#x2009;&#x00B1;&#x2009;10.7</td>
<td align="center" valign="top">91.0&#x2009;&#x00B1;&#x2009;9.9</td>
<td align="center" valign="top">89.8&#x2009;&#x00B1;&#x2009;10.4</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Glucose, mg/dL</td>
<td align="center" valign="top">87.2&#x2009;&#x00B1;&#x2009;17.7</td>
<td align="center" valign="top">86.1&#x2009;&#x00B1;&#x2009;15.5</td>
<td align="center" valign="top">85.3&#x2009;&#x00B1;&#x2009;13.6</td>
<td align="center" valign="top">0.030</td>
<td align="center" valign="top">104.5&#x2009;&#x00B1;&#x2009;25.3</td>
<td align="center" valign="top">103.8&#x2009;&#x00B1;&#x2009;19.2</td>
<td align="center" valign="top">103.1&#x2009;&#x00B1;&#x2009;23.6</td>
<td align="center" valign="top">0.659</td>
</tr>
<tr>
<td align="left" valign="top">Insulin, IU/</td>
<td align="center" valign="top">6.9&#x2009;&#x00B1;&#x2009;3.8</td>
<td align="center" valign="top">6.5&#x2009;&#x00B1;&#x2009;3.3</td>
<td align="center" valign="top">6.2&#x2009;&#x00B1;&#x2009;3.0</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">10.3&#x2009;&#x00B1;&#x2009;6.7</td>
<td align="center" valign="top">9.7&#x2009;&#x00B1;&#x2009;7.5</td>
<td align="center" valign="top">7.8&#x2009;&#x00B1;&#x2009;5.6</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Total cholesterol, mg/dL</td>
<td align="center" valign="top">192.0&#x2009;&#x00B1;&#x2009;34.8</td>
<td align="center" valign="top">192.0&#x2009;&#x00B1;&#x2009;35.9</td>
<td align="center" valign="top">186.2&#x2009;&#x00B1;&#x2009;34.4</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">191.1&#x2009;&#x00B1;&#x2009;39.1</td>
<td align="center" valign="top">186.1&#x2009;&#x00B1;&#x2009;39.4</td>
<td align="center" valign="top">187.8&#x2009;&#x00B1;&#x2009;39.0</td>
<td align="center" valign="top">0.201</td>
</tr>
<tr>
<td align="left" valign="top">Triglyceride, mg/dL</td>
<td align="center" valign="top">160.2&#x2009;&#x00B1;&#x2009;99.7</td>
<td align="center" valign="top">147.4&#x2009;&#x00B1;&#x2009;97.9</td>
<td align="center" valign="top">134.7&#x2009;&#x00B1;&#x2009;82.9</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">163.6&#x2009;&#x00B1;&#x2009;164.1</td>
<td align="center" valign="top">142.1&#x2009;&#x00B1;&#x2009;118.5</td>
<td align="center" valign="top">121.2&#x2009;&#x00B1;&#x2009;75.7</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">HDL cholesterol, mg/dL</td>
<td align="center" valign="top">45.7&#x2009;&#x00B1;&#x2009;9.7</td>
<td align="center" valign="top">45.6&#x2009;&#x00B1;&#x2009;9.4</td>
<td align="center" valign="top">46.2&#x2009;&#x00B1;&#x2009;10.8</td>
<td align="center" valign="top">0.335</td>
<td align="center" valign="top">48.2&#x2009;&#x00B1;&#x2009;12.0</td>
<td align="center" valign="top">47.9&#x2009;&#x00B1;&#x2009;10.0</td>
<td align="center" valign="top">49.5&#x2009;&#x00B1;&#x2009;11.8</td>
<td align="center" valign="top">0.087</td>
</tr>
<tr>
<td align="left" valign="top">WBC, 10<sup>9</sup>/&#x03BC;L</td>
<td align="center" valign="top">6.9&#x2009;&#x00B1;&#x2009;1.8</td>
<td align="center" valign="top">6.7&#x2009;&#x00B1;&#x2009;1.8</td>
<td align="center" valign="top">6.4&#x2009;&#x00B1;&#x2009;1.8</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">6.5&#x2009;&#x00B1;&#x2009;1.7</td>
<td align="center" valign="top">6.3&#x2009;&#x00B1;&#x2009;1.6</td>
<td align="center" valign="top">5.9&#x2009;&#x00B1;&#x2009;1.5</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Education level, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.858</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.414</td>
</tr>
<tr>
<td align="left" valign="top">Elementary/middle school</td>
<td align="center" valign="top">475 (42.2%)</td>
<td align="center" valign="top">397 (40.8%)</td>
<td align="center" valign="top">329 (40.5%)</td>
<td/>
<td align="center" valign="top">61 (14.5%)</td>
<td align="center" valign="top">44 (14.2%)</td>
<td align="center" valign="top">85 (18.7%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">High school</td>
<td align="center" valign="top">412 (36.6%)</td>
<td align="center" valign="top">354 (36.4%)</td>
<td align="center" valign="top">296 (36.4%)</td>
<td/>
<td align="center" valign="top">119 (28.3%)</td>
<td align="center" valign="top">87 (28.1%)</td>
<td align="center" valign="top">119 (26.2%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">College/university</td>
<td align="center" valign="top">239 (21.2%)</td>
<td align="center" valign="top">221 (22.7%)</td>
<td align="center" valign="top">188 (23.1%)</td>
<td/>
<td align="center" valign="top">240 (57.1%)</td>
<td align="center" valign="top">179 (57.7%)</td>
<td align="center" valign="top">251 (55.2%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Household income, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.267</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.394</td>
</tr>
<tr>
<td align="left" valign="top">&#x003C;100 million Korean Won</td>
<td align="center" valign="top">288 (25.7%)</td>
<td align="center" valign="top">266 (27.5%)</td>
<td align="center" valign="top">234 (28.7%)</td>
<td/>
<td align="center" valign="top">125 (30.0%)</td>
<td align="center" valign="top">103 (33.3%)</td>
<td align="center" valign="top">165 (36.4%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">100&#x2013;200 million Korean Won</td>
<td align="center" valign="top">345 (30.8%)</td>
<td align="center" valign="top">278 (28.7%)</td>
<td align="center" valign="top">257 (31.6%)</td>
<td/>
<td align="center" valign="top">145 (34.8%)</td>
<td align="center" valign="top">103 (33.3%)</td>
<td align="center" valign="top">145 (32.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x003E;200 million Korean Won</td>
<td align="center" valign="top">487 (43.5%)</td>
<td align="center" valign="top">425 (43.9%)</td>
<td align="center" valign="top">323 (39.7%)</td>
<td/>
<td align="center" valign="top">147 (35.3%)</td>
<td align="center" valign="top">103 (33.3%)</td>
<td align="center" valign="top">143 (31.6%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Energy intake, kcal/day</td>
<td align="center" valign="top">1895.2&#x2009;&#x00B1;&#x2009;593.2</td>
<td align="center" valign="top">2034.1&#x2009;&#x00B1;&#x2009;680.7</td>
<td align="center" valign="top">2178.1&#x2009;&#x00B1;&#x2009;749.7</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">2231.6&#x2009;&#x00B1;&#x2009;975.2</td>
<td align="center" valign="top">2243.5&#x2009;&#x00B1;&#x2009;917.7</td>
<td align="center" valign="top">2113.0&#x2009;&#x00B1;&#x2009;758.9</td>
<td align="center" valign="top">0.063</td>
</tr>
<tr>
<td align="left" valign="top">Number of MetS components, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">0</td>
<td align="center" valign="top">211 (18.7%)</td>
<td align="center" valign="top">273 (27.9%)</td>
<td align="center" valign="top">234 (28.7%)</td>
<td/>
<td align="center" valign="top">103 (24.5%)</td>
<td align="center" valign="top">76 (24.5%)</td>
<td align="center" valign="top">146 (32.1%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">1</td>
<td align="center" valign="top">405 (35.9%)</td>
<td align="center" valign="top">365 (37.4%)</td>
<td align="center" valign="top">353 (43.3%)</td>
<td/>
<td align="center" valign="top">77 (18.3%)</td>
<td align="center" valign="top">59 (19.0%)</td>
<td align="center" valign="top">103 (22.6%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="center" valign="top">512 (45.4%)</td>
<td align="center" valign="top">339 (34.7%)</td>
<td align="center" valign="top">229 (28.1%)</td>
<td/>
<td align="center" valign="top">85 (20.2%)</td>
<td align="center" valign="top">78 (25.2%)</td>
<td align="center" valign="top">97 (21.3%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x2265;3</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">&#x2013;</td>
<td align="center" valign="top">&#x2013;</td>
<td/>
<td align="center" valign="top">155 (37.0%)</td>
<td align="center" valign="top">97 (31.3%)</td>
<td align="center" valign="top">109 (24.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Saturated fatty acid, g/day</td>
<td align="center" valign="top">9.8&#x2009;&#x00B1;&#x2009;5.4</td>
<td align="center" valign="top">11.4&#x2009;&#x00B1;&#x2009;6.9</td>
<td align="center" valign="top">12.1&#x2009;&#x00B1;&#x2009;7.6</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">21.2&#x2009;&#x00B1;&#x2009;16.4</td>
<td align="center" valign="top">17.4&#x2009;&#x00B1;&#x2009;12.9</td>
<td align="center" valign="top">14.2&#x2009;&#x00B1;&#x2009;11.7</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Total iron intake, mg/day</td>
<td align="center" valign="top">17.6&#x2009;&#x00B1;&#x2009;8.0</td>
<td align="center" valign="top">20.2&#x2009;&#x00B1;&#x2009;9.6</td>
<td align="center" valign="top">22.8&#x2009;&#x00B1;&#x2009;10.7</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">11.5&#x2009;&#x00B1;&#x2009;9.5</td>
<td align="center" valign="top">12.2&#x2009;&#x00B1;&#x2009;7.7</td>
<td align="center" valign="top">11.5&#x2009;&#x00B1;&#x2009;7.1</td>
<td align="center" valign="top">0.406</td>
</tr>
<tr>
<td align="left" valign="top">Smoking status, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Current smoker</td>
<td align="center" valign="top">727 (64.5%)</td>
<td align="center" valign="top">466 (47.7%)</td>
<td align="center" valign="top">215 (26.3%)</td>
<td/>
<td align="center" valign="top">168 (40.0%)</td>
<td align="center" valign="top">90 (29.0%)</td>
<td align="center" valign="top">50 (11.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Former smoker</td>
<td align="center" valign="top">294 (26.1%)</td>
<td align="center" valign="top">309 (31.6%)</td>
<td align="center" valign="top">261 (32.0%)</td>
<td/>
<td align="center" valign="top">171 (40.7%)</td>
<td align="center" valign="top">119 (38.4%)</td>
<td align="center" valign="top">208 (45.7%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Never smoker</td>
<td align="center" valign="top">107 (9.5%)</td>
<td align="center" valign="top">202 (20.7%)</td>
<td align="center" valign="top">340 (41.7%)</td>
<td/>
<td align="center" valign="top">81 (19.3%)</td>
<td align="center" valign="top">101 (32.6%)</td>
<td align="center" valign="top">197 (43.3%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Drinking status, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Heavy drinker</td>
<td align="center" valign="top">320 (28.4%)</td>
<td align="center" valign="top">188 (19.2%)</td>
<td align="center" valign="top">62 (7.6%)</td>
<td/>
<td align="center" valign="top">101 (24.0%)</td>
<td align="center" valign="top">35 (11.3%)</td>
<td align="center" valign="top">32 (7.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Mild to moderate drinker</td>
<td align="center" valign="top">637 (56.5%)</td>
<td align="center" valign="top">524 (53.6%)</td>
<td align="center" valign="top">375 (46.0%)</td>
<td/>
<td align="center" valign="top">247 (58.8%)</td>
<td align="center" valign="top">169 (54.5%)</td>
<td align="center" valign="top">200 (44.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Non-drinker</td>
<td align="center" valign="top">171 (15.2%)</td>
<td align="center" valign="top">265 (27.1%)</td>
<td align="center" valign="top">379 (46.4%)</td>
<td/>
<td align="center" valign="top">72 (17.1%)</td>
<td align="center" valign="top">106 (34.2%)</td>
<td align="center" valign="top">223 (49.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Obesity status, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Obese</td>
<td align="center" valign="top">491 (43.5%)</td>
<td align="center" valign="top">240 (24.6%)</td>
<td align="center" valign="top">102 (12.5%)</td>
<td/>
<td align="center" valign="top">273 (65.0%)</td>
<td align="center" valign="top">150 (48.4%)</td>
<td align="center" valign="top">108 (23.7%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Overweight</td>
<td align="center" valign="top">313 (27.7%)</td>
<td align="center" valign="top">323 (33.1%)</td>
<td align="center" valign="top">226 (27.7%)</td>
<td/>
<td align="center" valign="top">87 (20.7%)</td>
<td align="center" valign="top">82 (26.5%)</td>
<td align="center" valign="top">132 (29.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Normal weight</td>
<td align="center" valign="top">324 (28.7%)</td>
<td align="center" valign="top">414 (42.4%)</td>
<td align="center" valign="top">488 (59.8%)</td>
<td/>
<td align="center" valign="top">60 (14.3%)</td>
<td align="center" valign="top">78 (25.2%)</td>
<td align="center" valign="top">215 (47.3%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Abdominal obesity, n (%)</td>
<td align="center" valign="top">157 (13.9%)</td>
<td align="center" valign="top">55 (5.6%)</td>
<td align="center" valign="top">18 (2.2%)</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">148 (35.2%)</td>
<td align="center" valign="top">73 (23.5%)</td>
<td align="center" valign="top">59 (13.0%)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Omega-3/omega-6 PUFA ratio</td>
<td align="center" valign="top">0.139&#x2009;&#x00B1;&#x2009;0.040</td>
<td align="center" valign="top">0.155&#x2009;&#x00B1;&#x2009;0.048</td>
<td align="center" valign="top">0.171&#x2009;&#x00B1;&#x2009;0.056</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">0.158&#x2009;&#x00B1;&#x2009;0.175</td>
<td align="center" valign="top">0.204&#x2009;&#x00B1;&#x2009;0.165</td>
<td align="center" valign="top">0.240&#x2009;&#x00B1;&#x2009;0.176</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Vitamin C intake, mg/day</td>
<td align="center" valign="top">80.3&#x2009;&#x00B1;&#x2009;58.6</td>
<td align="center" valign="top">122.3&#x2009;&#x00B1;&#x2009;87.5</td>
<td align="center" valign="top">161.2&#x2009;&#x00B1;&#x2009;122.8</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">51.1&#x2009;&#x00B1;&#x2009;165.5</td>
<td align="center" valign="top">77.6&#x2009;&#x00B1;&#x2009;132.5</td>
<td align="center" valign="top">95.5&#x2009;&#x00B1;&#x2009;86.1</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Vitamin E intake, mg/day</td>
<td align="center" valign="top">11.7&#x2009;&#x00B1;&#x2009;5.7</td>
<td align="center" valign="top">14.6&#x2009;&#x00B1;&#x2009;7.3</td>
<td align="center" valign="top">17.4&#x2009;&#x00B1;&#x2009;8.0</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">7.1&#x2009;&#x00B1;&#x2009;4.6</td>
<td align="center" valign="top">8.4&#x2009;&#x00B1;&#x2009;4.4</td>
<td align="center" valign="top">8.7&#x2009;&#x00B1;&#x2009;3.8</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Beta-carotene intake, &#x03BC;g/day</td>
<td align="center" valign="top">2564.1&#x2009;&#x00B1;&#x2009;2134.9</td>
<td align="center" valign="top">3766.0&#x2009;&#x00B1;&#x2009;3078.5</td>
<td align="center" valign="top">4905.9&#x2009;&#x00B1;&#x2009;3687.3</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">2183.1&#x2009;&#x00B1;&#x2009;2501.2</td>
<td align="center" valign="top">3286.5&#x2009;&#x00B1;&#x2009;3360.4</td>
<td align="center" valign="top">4350.8&#x2009;&#x00B1;&#x2009;4891.9</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Physical activity, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Low (&#x003C;7.5 METs-hr/day)</td>
<td align="center" valign="top">113 (10.0%)</td>
<td align="center" valign="top">39 (4.0%)</td>
<td align="center" valign="top">18 (2.2%)</td>
<td/>
<td align="center" valign="top">242 (57.6%)</td>
<td align="center" valign="top">140 (45.2%)</td>
<td align="center" valign="top">153 (33.6%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Moderate (7.5&#x2013;30 METs-hr/day)</td>
<td align="center" valign="top">720 (63.8%)</td>
<td align="center" valign="top">563 (57.6%)</td>
<td align="center" valign="top">428 (52.5%)</td>
<td/>
<td align="center" valign="top">128 (30.5%)</td>
<td align="center" valign="top">122 (39.4%)</td>
<td align="center" valign="top">209 (45.9%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">High (&#x003E;30 METs-hr/day)</td>
<td align="center" valign="top">295 (26.2%)</td>
<td align="center" valign="top">375 (38.4%)</td>
<td align="center" valign="top">370 (45.3%)</td>
<td/>
<td align="center" valign="top">50 (11.9%)</td>
<td align="center" valign="top">48 (15.5%)</td>
<td align="center" valign="top">93 (20.4%)</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2"><label>&#x002A;</label><p><italic>p</italic> value for the comparison of the baseline characteristics among sex-specific tertile groups of oxidative balance score at the baseline survey.</p></fn>
<p>Significance was set at <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05.</p>
<p>KoGES, Korean Genome and Epidemiology Study; KNHANES, Korean National Health and Nutrition Examination Survey; MBP, mean blood pressure; HDL, high-density lipoprotein; CRP, C-reactive protein; MetS, metabolic syndrome; PUFA, poly-unsaturated fatty acid; MET, metabolic equivalent of task.</p>
</table-wrap-foot>
</table-wrap>
<p>In the KNHANES, the T3 men had older age and lower MBP, insulin, triglyceride, and WBC. The proportion of MetS was significantly higher in T1 men. The T3 men had lower intake of SFA, and higher intake of omega-3 to omega-6 PUFA ratio, vitamin C, vitamin E, and beta-carotene. The T3 men exhibited lower proportions of current smokers, heavy drinkers, obese, and abdominal obesity and greater high intensity physical activity in both the KoGES and KNHANES.</p>
<p><xref rid="tab3" ref-type="table">Table 3</xref> shows the baseline characteristics of the women according to OBS tertile in the KoGES and KNHANES, respectively. In the KoGES, the T3 women had lower MBP, insulin, total cholesterol, triglyceride, and WBC. The proportion of participants with two MetS components was lowest in the T3 group. T3 women had higher intake of SFA, total iron, omega-3 to omega-6 PUFA ratio, vitamin C, vitamin E, and beta-carotene.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Baseline characteristics of women in the KoGES and 2021 KNHANES.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top" colspan="8">Oxidative balance score tertiles</th>
</tr>
<tr>
<th/>
<th align="center" valign="top" colspan="3">Women in KoGES</th>
<th/>
<th align="center" valign="top" colspan="3">Women in 2021KNHANES</th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Variables</td>
<td align="center" valign="top">T1 (<italic>n</italic> =&#x2009;828)</td>
<td align="center" valign="top">T2 (<italic>n</italic> =&#x2009;1,027)</td>
<td align="center" valign="top">T3 (<italic>n</italic> =&#x2009;1,031)</td>
<td align="center" valign="top"><italic>p</italic><xref rid="tfn3" ref-type="table-fn"><italic><sup>&#x002A;</sup></italic></xref></td>
<td align="center" valign="top">T1 (<italic>n</italic> =&#x2009;611)</td>
<td align="center" valign="top">T2 (<italic>n</italic> =&#x2009;481)</td>
<td align="center" valign="top">T3 (<italic>n</italic> =&#x2009;458)</td>
<td align="center" valign="top"><italic>p</italic><xref rid="tfn3" ref-type="table-fn"><italic><sup>&#x002A;</sup></italic></xref></td>
</tr>
<tr>
<td align="left" valign="top">Age, years</td>
<td align="center" valign="top">51.6&#x2009;&#x00B1;&#x2009;8.7</td>
<td align="center" valign="top">50.6&#x2009;&#x00B1;&#x2009;8.6</td>
<td align="center" valign="top">49.1&#x2009;&#x00B1;&#x2009;8.1</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">47.7&#x2009;&#x00B1;&#x2009;16.4</td>
<td align="center" valign="top">51.2&#x2009;&#x00B1;&#x2009;16.3</td>
<td align="center" valign="top">54.8&#x2009;&#x00B1;&#x2009;14.9</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">MBP, mmHg</td>
<td align="center" valign="top">91.9&#x2009;&#x00B1;&#x2009;12.5</td>
<td align="center" valign="top">91.3&#x2009;&#x00B1;&#x2009;12.1</td>
<td align="center" valign="top">89.8&#x2009;&#x00B1;&#x2009;12.1</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">86.8&#x2009;&#x00B1;&#x2009;11.0</td>
<td align="center" valign="top">86.0&#x2009;&#x00B1;&#x2009;10.3</td>
<td align="center" valign="top">86.6&#x2009;&#x00B1;&#x2009;11.4</td>
<td align="center" valign="top">0.478</td>
</tr>
<tr>
<td align="left" valign="top">Glucose, mg/dL</td>
<td align="center" valign="top">82.4&#x2009;&#x00B1;&#x2009;12.0</td>
<td align="center" valign="top">81.3&#x2009;&#x00B1;&#x2009;11.5</td>
<td align="center" valign="top">81.2&#x2009;&#x00B1;&#x2009;13.0</td>
<td align="center" valign="top">0.061</td>
<td align="center" valign="top">98.9&#x2009;&#x00B1;&#x2009;18.2</td>
<td align="center" valign="top">98.9&#x2009;&#x00B1;&#x2009;18.5</td>
<td align="center" valign="top">98.5&#x2009;&#x00B1;&#x2009;15.4</td>
<td align="center" valign="top">0.928</td>
</tr>
<tr>
<td align="left" valign="top">Insulin, IU/</td>
<td align="center" valign="top">7.9&#x2009;&#x00B1;&#x2009;5.7</td>
<td align="center" valign="top">7.5&#x2009;&#x00B1;&#x2009;4.0</td>
<td align="center" valign="top">7.2&#x2009;&#x00B1;&#x2009;4.2</td>
<td align="center" valign="top">0.010</td>
<td align="center" valign="top">9.5&#x2009;&#x00B1;&#x2009;6.2</td>
<td align="center" valign="top">8.8&#x2009;&#x00B1;&#x2009;8.5</td>
<td align="center" valign="top">7.2&#x2009;&#x00B1;&#x2009;5.0</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Total cholesterol, mg/dL</td>
<td align="center" valign="top">191.4&#x2009;&#x00B1;&#x2009;35.0</td>
<td align="center" valign="top">187.2&#x2009;&#x00B1;&#x2009;34.8</td>
<td align="center" valign="top">182.6&#x2009;&#x00B1;&#x2009;32.1</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">190.9&#x2009;&#x00B1;&#x2009;37.4</td>
<td align="center" valign="top">189.0&#x2009;&#x00B1;&#x2009;37.3</td>
<td align="center" valign="top">193.7&#x2009;&#x00B1;&#x2009;38.3</td>
<td align="center" valign="top">0.165</td>
</tr>
<tr>
<td align="left" valign="top">Triglyceride, mg/dL</td>
<td align="center" valign="top">119.4&#x2009;&#x00B1;&#x2009;49.0</td>
<td align="center" valign="top">117.1&#x2009;&#x00B1;&#x2009;45.9</td>
<td align="center" valign="top">113.1&#x2009;&#x00B1;&#x2009;51.2</td>
<td align="center" valign="top">0.017</td>
<td align="center" valign="top">112.2&#x2009;&#x00B1;&#x2009;73.0</td>
<td align="center" valign="top">103.7&#x2009;&#x00B1;&#x2009;67.6</td>
<td align="center" valign="top">97.0&#x2009;&#x00B1;&#x2009;67.3</td>
<td align="center" valign="top">0.002</td>
</tr>
<tr>
<td align="left" valign="top">HDL cholesterol, mg/dL</td>
<td align="center" valign="top">48.2&#x2009;&#x00B1;&#x2009;10.2</td>
<td align="center" valign="top">48.5&#x2009;&#x00B1;&#x2009;10.3</td>
<td align="center" valign="top">48.6&#x2009;&#x00B1;&#x2009;9.9</td>
<td align="center" valign="top">0.711</td>
<td align="center" valign="top">55.3&#x2009;&#x00B1;&#x2009;12.9</td>
<td align="center" valign="top">56.2&#x2009;&#x00B1;&#x2009;13.3</td>
<td align="center" valign="top">58.0&#x2009;&#x00B1;&#x2009;13.5</td>
<td align="center" valign="top">0.005</td>
</tr>
<tr>
<td align="left" valign="top">WBC, 10<sup>9</sup>/&#x03BC;L</td>
<td align="center" valign="top">6.3&#x2009;&#x00B1;&#x2009;1.8</td>
<td align="center" valign="top">6.2&#x2009;&#x00B1;&#x2009;1.7</td>
<td align="center" valign="top">6.0&#x2009;&#x00B1;&#x2009;1.7</td>
<td align="center" valign="top">0.001</td>
<td align="center" valign="top">5.9&#x2009;&#x00B1;&#x2009;1.6</td>
<td align="center" valign="top">5.6&#x2009;&#x00B1;&#x2009;1.5</td>
<td align="center" valign="top">5.4&#x2009;&#x00B1;&#x2009;1.5</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Education level, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.462</td>
</tr>
<tr>
<td align="left" valign="top">Elementary/middle school</td>
<td align="center" valign="top">558 (67.7%)</td>
<td align="center" valign="top">640 (62.7%)</td>
<td align="center" valign="top">540 (52.6%)</td>
<td/>
<td align="center" valign="top">147 (24.1%)</td>
<td align="center" valign="top">115 (23.9%)</td>
<td align="center" valign="top">111 (24.2%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">High school</td>
<td align="center" valign="top">210 (25.5%)</td>
<td align="center" valign="top">316 (31.0%)</td>
<td align="center" valign="top">383 (37.3%)</td>
<td/>
<td align="center" valign="top">152 (24.9%)</td>
<td align="center" valign="top">131 (27.2%)</td>
<td align="center" valign="top">136 (29.7%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">College/university</td>
<td align="center" valign="top">56 (6.8%)</td>
<td align="center" valign="top">65 (6.4%)</td>
<td align="center" valign="top">104 (10.1%)</td>
<td/>
<td align="center" valign="top">312 (51.1%)</td>
<td align="center" valign="top">235 (48.9%)</td>
<td align="center" valign="top">211 (46.1%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Household income, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.358</td>
</tr>
<tr>
<td align="left" valign="top">&#x003C;100 million Korean Won</td>
<td align="center" valign="top">297 (36.4%)</td>
<td align="center" valign="top">346 (34.2%)</td>
<td align="center" valign="top">307 (30.3%)</td>
<td/>
<td align="center" valign="top">193 (31.6%)</td>
<td align="center" valign="top">151 (31.5%)</td>
<td align="center" valign="top">152 (33.3%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">100&#x2013;200 million Korean Won</td>
<td align="center" valign="top">256 (31.4%)</td>
<td align="center" valign="top">320 (31.7%)</td>
<td align="center" valign="top">292 (28.8%)</td>
<td/>
<td align="center" valign="top">223 (36.6%)</td>
<td align="center" valign="top">152 (31.7%)</td>
<td align="center" valign="top">152 (33.3%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x003E;200 million Korean Won</td>
<td align="center" valign="top">263 (32.2%)</td>
<td align="center" valign="top">345 (34.1%)</td>
<td align="center" valign="top">414 (40.9%)</td>
<td/>
<td align="center" valign="top">194 (31.8%)</td>
<td align="center" valign="top">177 (36.9%)</td>
<td align="center" valign="top">153 (33.5%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Energy intake, kcal/day</td>
<td align="center" valign="top">1727.4&#x2009;&#x00B1;&#x2009;544.0</td>
<td align="center" valign="top">1805.4&#x2009;&#x00B1;&#x2009;629.3</td>
<td align="center" valign="top">2120.2&#x2009;&#x00B1;&#x2009;848.0</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">1563.7&#x2009;&#x00B1;&#x2009;611.1</td>
<td align="center" valign="top">1578.7&#x2009;&#x00B1;&#x2009;601.8</td>
<td align="center" valign="top">1589.8&#x2009;&#x00B1;&#x2009;535.0</td>
<td align="center" valign="top">0.766</td>
</tr>
<tr>
<td align="left" valign="top">Number of MetS components, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.001</td>
</tr>
<tr>
<td align="left" valign="top">0</td>
<td align="center" valign="top">108 (13.0%)</td>
<td align="center" valign="top">214 (20.8%)</td>
<td align="center" valign="top">272 (26.4%)</td>
<td/>
<td align="center" valign="top">209 (34.2%)</td>
<td align="center" valign="top">178 (37.0%)</td>
<td align="center" valign="top">152 (33.2%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">1</td>
<td align="center" valign="top">296 (35.7%)</td>
<td align="center" valign="top">423 (41.2%)</td>
<td align="center" valign="top">452 (43.8%)</td>
<td/>
<td align="center" valign="top">137 (22.4%)</td>
<td align="center" valign="top">100 (20.8%)</td>
<td align="center" valign="top">133 (29.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="center" valign="top">424 (51.2%)</td>
<td align="center" valign="top">390 (38.0%)</td>
<td align="center" valign="top">307 (29.8%)</td>
<td/>
<td align="center" valign="top">100 (16.4%)</td>
<td align="center" valign="top">95 (19.8%)</td>
<td align="center" valign="top">88 (19.2%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x2265;3</td>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">165 (49.4%)</td>
<td align="center" valign="top">108 (22.4%)</td>
<td align="center" valign="top">85 (18.6%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Saturated fatty acid, g/day</td>
<td align="center" valign="top">9.3&#x2009;&#x00B1;&#x2009;5.0</td>
<td align="center" valign="top">10.6&#x2009;&#x00B1;&#x2009;6.3</td>
<td align="center" valign="top">12.9&#x2009;&#x00B1;&#x2009;9.3</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">15.2&#x2009;&#x00B1;&#x2009;11.3</td>
<td align="center" valign="top">12.9&#x2009;&#x00B1;&#x2009;9.8</td>
<td align="center" valign="top">10.3&#x2009;&#x00B1;&#x2009;7.7</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Total iron intake, mg/day</td>
<td align="center" valign="top">15.6&#x2009;&#x00B1;&#x2009;6.5</td>
<td align="center" valign="top">18.3&#x2009;&#x00B1;&#x2009;8.9</td>
<td align="center" valign="top">23.1&#x2009;&#x00B1;&#x2009;12.4</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">8.7&#x2009;&#x00B1;&#x2009;7.0</td>
<td align="center" valign="top">8.5&#x2009;&#x00B1;&#x2009;5.0</td>
<td align="center" valign="top">9.4&#x2009;&#x00B1;&#x2009;5.3</td>
<td align="center" valign="top">0.035</td>
</tr>
<tr>
<td align="left" valign="top">Smoking status, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Current smoker</td>
<td align="center" valign="top">49 (5.9%)</td>
<td align="center" valign="top">26 (2.5%)</td>
<td align="center" valign="top">6 (0.6%)</td>
<td/>
<td align="center" valign="top">54 (8.8%)</td>
<td align="center" valign="top">7 (1.5%)</td>
<td align="center" valign="top">2 (0.4%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Former smoker</td>
<td align="center" valign="top">17 (2.1%)</td>
<td align="center" valign="top">9 (0.9%)</td>
<td align="center" valign="top">3 (0.3%)</td>
<td/>
<td align="center" valign="top">49 (8.0%)</td>
<td align="center" valign="top">16 (3.3%)</td>
<td align="center" valign="top">9 (2.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Never smoker</td>
<td align="center" valign="top">762 (92.0%)</td>
<td align="center" valign="top">992 (96.6%)</td>
<td align="center" valign="top">1,022 (99.1%)</td>
<td/>
<td align="center" valign="top">508 (83.1%)</td>
<td align="center" valign="top">458 (95.2%)</td>
<td align="center" valign="top">447 (97.6%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Drinking status, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Heavy drinker</td>
<td align="center" valign="top">28 (3.4%)</td>
<td align="center" valign="top">10 (1.0%)</td>
<td align="center" valign="top">5 (0.5%)</td>
<td/>
<td align="center" valign="top">53 (8.7%)</td>
<td align="center" valign="top">11 (2.3%)</td>
<td align="center" valign="top">1 (0.2%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Mild to moderate drinker</td>
<td align="center" valign="top">327 (39.5%)</td>
<td align="center" valign="top">282 (27.5%)</td>
<td align="center" valign="top">187 (18.1%)</td>
<td/>
<td align="center" valign="top">273 (44.7%)</td>
<td align="center" valign="top">167 (34.7%)</td>
<td align="center" valign="top">110 (24.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Non-drinker</td>
<td align="center" valign="top">473 (57.1%)</td>
<td align="center" valign="top">735 (71.6%)</td>
<td align="center" valign="top">839 (81.4%)</td>
<td/>
<td align="center" valign="top">285 (46.6%)</td>
<td align="center" valign="top">303 (63.0%)</td>
<td align="center" valign="top">347 (75.8%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Obesity status, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Obese</td>
<td align="center" valign="top">452 (54.6%)</td>
<td align="center" valign="top">354 (34.5%)</td>
<td align="center" valign="top">138 (13.4%)</td>
<td/>
<td align="center" valign="top">272 (44.5%)</td>
<td align="center" valign="top">119 (24.7%)</td>
<td align="center" valign="top">52 (11.4%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Overweight</td>
<td align="center" valign="top">234 (28.3%)</td>
<td align="center" valign="top">306 (29.8%)</td>
<td align="center" valign="top">295 (28.6%)</td>
<td/>
<td align="center" valign="top">122 (20.0%)</td>
<td align="center" valign="top">121 (25.2%)</td>
<td align="center" valign="top">99 (21.6%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Normal weight</td>
<td align="center" valign="top">142 (17.1%)</td>
<td align="center" valign="top">367 (35.7%)</td>
<td align="center" valign="top">598 (58.0%)</td>
<td/>
<td align="center" valign="top">217 (35.5%)</td>
<td align="center" valign="top">241 (50.1%)</td>
<td align="center" valign="top">307 (67.0%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Abdominal obesity, n (%)</td>
<td align="center" valign="top">259 (31.3%)</td>
<td align="center" valign="top">151 (14.7%)</td>
<td align="center" valign="top">57 (5.5%)</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">99 (16.2%)</td>
<td align="center" valign="top">44 (9.1%)</td>
<td align="center" valign="top">8 (1.7%)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Omega-3/omega-6 PUFA ratio</td>
<td align="center" valign="top">0.134&#x2009;&#x00B1;&#x2009;0.037</td>
<td align="center" valign="top">0.154&#x2009;&#x00B1;&#x2009;0.053</td>
<td align="center" valign="top">0.175&#x2009;&#x00B1;&#x2009;0.067</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">0.177&#x2009;&#x00B1;&#x2009;0.190</td>
<td align="center" valign="top">0.239&#x2009;&#x00B1;&#x2009;0.249</td>
<td align="center" valign="top">0.295&#x2009;&#x00B1;&#x2009;0.268</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Vitamin C intake, mg/day</td>
<td align="center" valign="top">82.8&#x2009;&#x00B1;&#x2009;65.4</td>
<td align="center" valign="top">123.6&#x2009;&#x00B1;&#x2009;110.1</td>
<td align="center" valign="top">194.1&#x2009;&#x00B1;&#x2009;147.0</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">38.2&#x2009;&#x00B1;&#x2009;46.4</td>
<td align="center" valign="top">66.1&#x2009;&#x00B1;&#x2009;78.7</td>
<td align="center" valign="top">106.3&#x2009;&#x00B1;&#x2009;114.9</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Vitamin E intake, mg/day</td>
<td align="center" valign="top">10.3&#x2009;&#x00B1;&#x2009;5.7</td>
<td align="center" valign="top">13.1&#x2009;&#x00B1;&#x2009;7.1</td>
<td align="center" valign="top">18.3&#x2009;&#x00B1;&#x2009;10.9</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">5.6&#x2009;&#x00B1;&#x2009;3.2</td>
<td align="center" valign="top">6.4&#x2009;&#x00B1;&#x2009;3.6</td>
<td align="center" valign="top">7.4&#x2009;&#x00B1;&#x2009;3.4</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Beta-carotene intake, &#x03BC;g/day</td>
<td align="center" valign="top">2095.2&#x2009;&#x00B1;&#x2009;1456.3</td>
<td align="center" valign="top">3144.4&#x2009;&#x00B1;&#x2009;2730.2</td>
<td align="center" valign="top">5089.7&#x2009;&#x00B1;&#x2009;4572.1</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">1757.6&#x2009;&#x00B1;&#x2009;1782.7</td>
<td align="center" valign="top">2690.9&#x2009;&#x00B1;&#x2009;2388.5</td>
<td align="center" valign="top">4602.5&#x2009;&#x00B1;&#x2009;4064.0</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Physical activity, n (%)</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
<td/>
<td/>
<td/>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Low (&#x003C;7.5 METs-hr/day)</td>
<td align="center" valign="top">127 (15.3%)</td>
<td align="center" valign="top">75 (7.3%)</td>
<td align="center" valign="top">53 (5.1%)</td>
<td/>
<td align="center" valign="top">357 (58.4%)</td>
<td align="center" valign="top">221 (45.9%)</td>
<td align="center" valign="top">170 (37.1%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Moderate (7.5&#x2013;30 METs-hr/day)</td>
<td align="center" valign="top">560 (67.6%)</td>
<td align="center" valign="top">702 (68.4%)</td>
<td align="center" valign="top">648 (62.9%)</td>
<td/>
<td align="center" valign="top">213 (34.9%)</td>
<td align="center" valign="top">223 (46.4%)</td>
<td align="center" valign="top">218 (47.6%)</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">High (&#x003E;30 METs-hr/day)</td>
<td align="center" valign="top">141 (17.0%)</td>
<td align="center" valign="top">250 (24.3%)</td>
<td align="center" valign="top">330 (32.0%)</td>
<td/>
<td align="center" valign="top">41 (6.7%)</td>
<td align="center" valign="top">37 (7.7%)</td>
<td align="center" valign="top">70 (15.3%)</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn3"><label>&#x002A;</label><p><italic>p</italic> value for the comparison of the baseline characteristics among sex-specific tertile groups of oxidative balance score at the baseline survey.</p></fn>
<p>Significance was set at <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05.</p>
<p>KoGES, Korean Genome and Epidemiology Study; KNHANES, Korean National Health and Nutrition Examination Survey; MBP, mean blood pressure; HDL, high-density lipoprotein; CRP, C-reactive protein; MetS, metabolic syndrome; PUFA, poly-unsaturated fatty acid; MET, metabolic equivalent of task.</p>
</table-wrap-foot>
</table-wrap>
<p>In the KNHANES, the T3 women had older age and higher HDL-cholesterol, but lower insulin, triglyceride, and WBC. The proportion of MetS was significantly higher in T1 women. The T3 women had lower intake of SFA and higher intake of omega-3 to omega-6 PUFA ratio, vitamin C, vitamin E, and beta-carotene. The T3 women had lower proportions of current smokers, heavy drinkers, obese, and abdominal obesity and greater high intensity physical activity in both the KoGES and KNHANES.</p>
</sec>
<sec id="sec10">
<label>3.2.</label>
<title>Longitudinal association of OBS with incident MetS</title>
<p>During the mean 13.6-year follow-up period, 1,296 (44.4%) men and 880 (30.5%) women developed new-onset MetS in the KoGES. Baseline characteristics of men and women from KoGES are shown in <xref rid="SM1" ref-type="supplementary-material">Supplementary Table 3</xref>. Inverse relationships were noted between OBS and the risk of incident MetS in both men (<xref rid="fig2" ref-type="fig">Figure 2A</xref>) and women (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). <xref rid="fig3" ref-type="fig">Figure 3</xref> presents the cumulative incidence rates of MetS as Kaplan&#x2013;Meier curves according to sex-specific OBS tertiles in the KoGES. The T3 group showed the lowest cumulative incidence of MetS, followed by the T2 and T1 groups, among both men (<xref rid="fig3" ref-type="fig">Figure 3A</xref>) and women (<xref rid="fig3" ref-type="fig">Figure 3B</xref>) (both log-rank test <italic>p</italic>-values &#x003C;0.001).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Cox proportional hazard spline curves showing an inverse relationship between oxidative balance scores and the risk of incident metabolic syndrome. The blue line illustrates changes in hazard ratios for the incidence of metabolic syndrome across a range of OBS values. The sky-blue area represents 95% confidence intervals. The red line indicates a hazard ratio of one. The gray shaded area denotes a density plot showing the distribution of the study population according to OBS values. <bold>(A)</bold> Men, <bold>(B)</bold> Women.</p>
</caption>
<graphic xlink:href="fnut-10-1226107-g002.tif"/>
</fig>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Kaplan&#x2013;Meier curves of cumulative incidence rates of metabolic syndrome according to sex-specific oxidative balance score tertiles for <bold>(A)</bold> men and <bold>(B)</bold> women. <sup>&#x002A;</sup>Number at risk refers to those individuals at each time point who are still under observation and have not yet experienced metabolic syndrome.</p>
</caption>
<graphic xlink:href="fnut-10-1226107-g003.tif"/>
</fig>
<p><xref rid="tab4" ref-type="table">Table 4</xref> shows the independent association between OBS tertiles and MetS in the KoGES and the 2021 KNHANES. In the KoGES, the HRs (95% CIs) for new-onset MetS per increment in OBS were 0.90 (0.88&#x2013;0.92) in men and 0.88 (0.86&#x2013;0.91) in women. Compared to referent T1, the adjusted HRs (95% CIs) for new-onset MetS were 0.82 (0.72&#x2013;0.93) in T2 and 0.56 (0.48&#x2013;0.62) in T3 among men. Compared to referent T1, the adjusted HRs (95% CIs) for new-onset MetS were 0.71 (0.62&#x2013;0.81) in T2 and 0.63 (0.55&#x2013;0.73) in T3 among women.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>Associations between oxidative balance score and incident/prevalent metabolic syndrome in KoGES and KNHANES.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="top" colspan="9">KoGES</th>
</tr>
<tr>
<th align="left" valign="top" rowspan="2">Oxidative balance score tertiles</th>
<th align="center" valign="top" rowspan="2">Numbers, n</th>
<th align="center" valign="top" rowspan="2">New-onset MetS cases, n</th>
<th align="center" valign="top" rowspan="2">Follow-up period, person-year</th>
<th align="center" valign="top" rowspan="2">Incidence rate per 1,000 person-years</th>
<th align="center" valign="top">Unadjusted</th>
<th/>
<th align="center" valign="top">Adjusted</th>
<th/>
</tr>
<tr>
<th align="center" valign="top">HR (95% CI)</th>
<th align="center" valign="top"><italic>p</italic>
</th>
<th align="center" valign="top">HR (95% CI)</th>
<th align="center" valign="top"><italic>p</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Men</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Continuous (per increment)</td>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.90 (0.88&#x2013;0.92)</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">0.90 (0.88&#x2013;0.92)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">T1</td>
<td align="center" valign="top">1,128</td>
<td align="center" valign="top">582</td>
<td align="center" valign="top">10028.0</td>
<td align="center" valign="top">58.0</td>
<td align="center" valign="top">1</td>
<td/>
<td align="center" valign="top">1</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">T2</td>
<td align="center" valign="top">977</td>
<td align="center" valign="top">440</td>
<td align="center" valign="top">9414.4</td>
<td align="center" valign="top">46.7</td>
<td align="center" valign="top">0.81 (0.72&#x2013;0.92)</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">0.82 (0.72&#x2013;0.93)</td>
<td align="center" valign="top">0.002</td>
</tr>
<tr>
<td align="left" valign="top">T3</td>
<td align="center" valign="top">816</td>
<td align="center" valign="top">274</td>
<td align="center" valign="top">8610.4</td>
<td align="center" valign="top">31.8</td>
<td align="center" valign="top">0.56 (0.48&#x2013;0.64)</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">0.56 (0.48&#x2013;0.65)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Women</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Continuous (per increment)</td>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.88 (0.86&#x2013;0.91)</td>
<td/>
<td align="center" valign="top">0.90 (0.88&#x2013;0.93)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">T1</td>
<td align="center" valign="top">828</td>
<td align="center" valign="top">452</td>
<td align="center" valign="top">7420.6</td>
<td align="center" valign="top">60.9</td>
<td align="center" valign="top">1</td>
<td/>
<td align="center" valign="top">1</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">T2</td>
<td align="center" valign="top">1,027</td>
<td align="center" valign="top">443</td>
<td align="center" valign="top">10264.1</td>
<td align="center" valign="top">43.2</td>
<td align="center" valign="top">0.71 (0.62&#x2013;0.81)</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">0.71 (0.62&#x2013;0.81)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">T3</td>
<td align="center" valign="top">1,031</td>
<td align="center" valign="top">388</td>
<td align="center" valign="top">11217.2</td>
<td align="center" valign="top">34.6</td>
<td align="center" valign="top">0.57 (0.50&#x2013;0.65)</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">0.63 (0.55&#x2013;0.73)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="center" valign="top" colspan="9">KNHANES</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Oxidative balance score tertiles</td>
<td align="center" valign="top" rowspan="2">Numbers, n</td>
<td align="center" valign="top" rowspan="2">MetS cases, n</td>
<td rowspan="2"/>
<td align="center" valign="top" rowspan="2">Prevalence rate of MetS, %</td>
<td align="center" valign="top">Unadjusted</td>
<td/>
<td align="center" valign="top">Adjusted</td>
<td/>
</tr>
<tr>
<td align="center" valign="top">OR (95% CI)</td>
<td align="center" valign="top"><italic>p</italic></td>
<td align="center" valign="top">OR (95% CI)</td>
<td align="center" valign="top"><italic>p</italic></td>
</tr>
<tr>
<td align="left" valign="top">Men</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Continuous (per increment)</td>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.89 (0.85&#x2013;0.93)</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">0.87 (0.81&#x2013;0.92)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">T1</td>
<td align="center" valign="top">420</td>
<td align="center" valign="top">155</td>
<td/>
<td align="center" valign="top">36.90</td>
<td align="center" valign="top">1</td>
<td/>
<td align="center" valign="top">1</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">T2</td>
<td align="center" valign="top">310</td>
<td align="center" valign="top">97</td>
<td/>
<td align="center" valign="top">31.29</td>
<td align="center" valign="top">0.78 (0.57&#x2013;1.06)</td>
<td align="center" valign="top">0.115</td>
<td align="center" valign="top">0.67 (0.45&#x2013;1.00)</td>
<td align="center" valign="top">0.051</td>
</tr>
<tr>
<td align="left" valign="top">T3</td>
<td align="center" valign="top">455</td>
<td align="center" valign="top">109</td>
<td/>
<td align="center" valign="top">23.96</td>
<td align="center" valign="top">0.54 (0.40&#x2013;0.72)</td>
<td align="center" valign="top">&#x003C;0.001</td>
<td align="center" valign="top">0.44 (0.29&#x2013;0.65)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Women</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Continuous (per increment)</td>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">0.88 (0.84&#x2013;0.93)</td>
<td/>
<td align="center" valign="top">0.80 (0.75&#x2013;0.86)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">T1</td>
<td align="center" valign="top">611</td>
<td align="center" valign="top">165</td>
<td/>
<td align="center" valign="top">27.00</td>
<td align="center" valign="top">1</td>
<td/>
<td align="center" valign="top">1</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">T2</td>
<td align="center" valign="top">481</td>
<td align="center" valign="top">108</td>
<td/>
<td align="center" valign="top">22.45</td>
<td align="center" valign="top">0.59 (0.59&#x2013;1.03)</td>
<td align="center" valign="top">0.085</td>
<td align="center" valign="top">0.58 (0.40&#x2013;0.86)</td>
<td align="center" valign="top">0.006</td>
</tr>
<tr>
<td align="left" valign="top">T3</td>
<td align="center" valign="top">458</td>
<td align="center" valign="top">85</td>
<td/>
<td align="center" valign="top">18.56</td>
<td align="center" valign="top">0.62 (0.46&#x2013;0.83)</td>
<td align="center" valign="top">0.001</td>
<td align="center" valign="top">0.34 (0.23&#x2013;0.50)</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Adjusted for age, education level, monthly household income, total energy intake, mean blood pressure, whole blood white blood cell count, fasting plasma glucose, and serum total cholesterol levels based on characteristics for each population. Significance was set at <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05.</p>
<p>KoGES, Korean Genome and Epidemiology Study; KNHANES, Korean National Health and Nutrition Examination Survey; MetS, metabolic syndrome; HR, hazard ratio; CI, confidence interval.</p>
</table-wrap-foot>
</table-wrap>
<p>In the 2021 KNHANES, the ORs (95% CIs) for MetS per increment in OBS were 0.89 (0.85&#x2013;0.93) in men and 0.88 (0.84&#x2013;0.93) in women. Compared to referent T1, the adjusted ORs (95% CIs) for MetS in T3 were 0.44 (0.29&#x2013;0.65) in men and 0.34 (0.23&#x2013;0.50) in women. When we conducted the subgroup analysis in adults aged 40&#x2013;69&#x2009;years from KNHANES, the significant association between OBS and incident MetS remained (T3 vs. T1, adjusted ORs and 95% CIs&#x2009;=&#x2009;0.39 [0.24&#x2013;0.65] in men and 0.26 [0.16&#x2013;0.43] in women) (<xref rid="SM1" ref-type="supplementary-material">Supplementary Table 4</xref>).</p>
</sec>
</sec>
<sec sec-type="discussions" id="sec11">
<label>4.</label>
<title>Discussion</title>
<p>We found that OBS was independently and inversely related to the prevalence of MetS and incident MetS in men and women separately after adjusting for potential confounders in both cross-sectional and longitudinal datasets.</p>
<p>Higher OBS values were closely associated with a lower risk of incident MetS. Our findings are line with previous studies that have demonstrated the association with chronic diseases such hypertension (<xref ref-type="bibr" rid="ref37">37</xref>), non-alcoholic fatty liver diseases (NAFLD) (<xref ref-type="bibr" rid="ref38">38</xref>), cardiovascular diseases (<xref ref-type="bibr" rid="ref39">39</xref>) and MetS (<xref ref-type="bibr" rid="ref18">18</xref>). While limited studies have reported on the link between OBS and MetS in Caucasian populations, Annor et al. found an inverse association between OBS and hypertension, a component of MetS, in a racially diverse population (<xref ref-type="bibr" rid="ref37">37</xref>). A cross-sectional study conducted in Korea found that higher OBS was associated with a lower risk of MetS (<xref ref-type="bibr" rid="ref18">18</xref>). The study further revealed that individuals in the highest OBS quartile exhibited lower levels of inflammatory markers, including white blood cell count and C-reactive protein. A recent study has revealed that OBS exhibits an inverse association with NAFLD, a condition sharing a similar spectrum with metabolic syndrome (<xref ref-type="bibr" rid="ref38">38</xref>).</p>
<p>In contrast to our current study, Noruzi et al. (<xref ref-type="bibr" rid="ref19">19</xref>) reported an inverse association between higher OBS values and a reduced likelihood of MetS components, such as abdominal obesity and elevated DBP, among an Iranian population. However, their study did not find a significant association between OBS and the overall prevalence of MetS or other individual MetS components. Several factors could explain the disparities observed in the previous study. One contributing factor is that the previous Iranian study did not include comprehensive data on alcohol consumption, which is an important component of OBS. Additionally, differences in demographic factors, including age, ethnicity, and the composition of participant samples, could contribute to the observed differences. Furthermore, variations in the composition of OBS components and discrepancies in sample sizes may also contribute to these disparities.</p>
<p>Many studies have suggested various OBS values with different scoring schemes and with different types of anti-and pro-oxidant components, including dietary factors and lifestyle factors (<xref ref-type="bibr" rid="ref14">14</xref>). Similar to previous studies, we aimed to construct an OBS using OBS components available in the KoGES and KNHANES as much as possible. Also, we found that higher scores for the OBS used in the current study were correlated with lower blood glucose, insulin, total cholesterol, triglyceride, and CRP.</p>
<p>There are several plausible explanations for the findings of this study. First, a higher OBS indicates a favorable antioxidant defense system, which can counteract excessive oxidative stress, a key contributor to MetS development (<xref ref-type="bibr" rid="ref10">10</xref>). Previous studies have indicated that healthy lifestyles that include aerobic exercise, high consumption of vegetables, alcohol restriction, and body weight control are associated with decreased blood pressure, insulin resistance, and other related diseases by controlling oxidative stress (<xref ref-type="bibr" rid="ref40">40</xref>, <xref ref-type="bibr" rid="ref41">41</xref>). Although the highest tertile group in KoGES showed the highest SFA and total iron intake, compared with the other tertile groups, this could be due to the tertile group having the highest total energy intake. However, considering that the relationship between OBS and incident MetS remained significant even after adjusting for total energy intake, the effect of antioxidants and lifestyle factors could outweigh that of the pro-oxidant components. Second, chronic systemic inflammation can contribute to the development of MetS. Chronic inflammation may worsen insulin action, increase blood pressure, and deteriorate lipid metabolism (<xref ref-type="bibr" rid="ref42">42</xref>, <xref ref-type="bibr" rid="ref43">43</xref>). A randomized controlled trial found that participants in the highest quartile of white blood cell counts had a higher probability of having MetS than those in the lowest baseline sex-adjusted quartile (OR: 2.47, 95% CI: 2.03&#x2013;2.99, p for trend &#x003C;0.001) (<xref ref-type="bibr" rid="ref44">44</xref>). Adopting a healthy dietary pattern characterized by a high intake of vegetables, nuts and fish, quitting smoking, and maintaining a healthy body weight are recognized as effective measures for mitigating chronic inflammation (<xref ref-type="bibr" rid="ref45">45</xref>). We found that OBS was negatively correlated with CRP in the current study. Third, elevated OBS values have the potential to enhance insulin sensitivity, facilitate efficient glucose utilization, and reduce the risk of insulin resistance, which is a crucial factor in the development of MetS. Physical activity improves peripheral insulin sensitivity (<xref ref-type="bibr" rid="ref46">46</xref>), while smoking can have detrimental effects on pancreatic &#x03B2;-cell function and insulin sensitivity (<xref ref-type="bibr" rid="ref47">47</xref>).</p>
<p>Finally, the metabolic overburden of mitochondria, which causes incomplete &#x03B2;-oxidation and an accumulation of lipotoxicity, is a major contributor to both &#x03B2;-cell dysfunction and muscle insulin resistance (<xref ref-type="bibr" rid="ref48">48</xref>). Moreover, a genome-wide association study revealed that the VEGF signaling pathway, glutathione metabolism, and the Rac-1 pathway were highly enhanced biological pathways associated with OBS and MetS (<xref ref-type="bibr" rid="ref18">18</xref>). Follow-up studies are needed to determine differences in genetic variations, such as single nucleotide polymorphisms, according to OBS values.</p>
<p>This study has some limitations. First, there were differences in sociodemographic factors and some items for the OBS between individuals included in the analysis and those excluded from the analysis (<xref rid="SM1" ref-type="supplementary-material">Supplementary Tables 5, 6</xref>). Thus, there is a possibility of selection bias. However, we analyzed the KOGES and KNHANES datasets separately and observed significant results in each analysis. We also found significant associations between OBS and MetS in adults who aged 40&#x2013;69&#x2009;years in the KNHANES. Second, in the analysis of the KoGES dataset, only OBS values from the baseline survey were considered due to the unavailability of follow-up information specifically related to diet. All variables included in the OBS can change over time. Therefore, in future studies, the effect of changes in OBS over time on the incidence of MetS should be analyzed. Third, information about dietary components was obtained from FFQs. Although FFQs are useful for investigating nutritional status in large-scale epidemiology studies, they lack accuracy on absolute nutrient values, especially micronutrients, and may over- or under-report consumption of certain foods (<xref ref-type="bibr" rid="ref49">49</xref>). Due to a lack of information, we could not consider blood micronutrient levels. In addition, there is a possibility of recall bias in the information on average intake over the past year. Fourth, each component included in the OBS may have distinct effects on MetS. It is important to consider an analysis method that takes into account the weights associated with each pro-oxidant and anti-oxidant component when assessing their impact on incident MetS. Further controlled clinical trials considering more detailed anti-and pro-oxidants components should be performed to confirm a causal relationship between OBS and incident MetS. Also, efforts are needed to construct a verified OBS. Finally, we could not consider the impact of all possible pro- and anti-inflammatory cytokines, including interleukin (IL)-1&#x03B2;, IL-4, IL-6, IL-10, and tumor necrosis factor-&#x03B1;.</p>
<p>Despite these limitations, we are the first to report a significant association between OBS and MetS in a large, population-based, prospective study with a long follow-up period. The present study found higher OBS values were significantly associated with lower incidences of MetS in two independent large population-based datasets. OBS-enhancing strategies, including maintaining a healthy weight, engaging in regular exercise, quitting smoking, and consuming antioxidant substances, may successfully reduce one&#x2019;s risk of developing MetS. It is imperative to conduct more randomized controlled studies to confirm the validity of authorized OBS diet recommendations for preventing MetS.</p>
</sec>
<sec sec-type="data-availability" id="sec12">
<title>Data availability statement</title>
<p>Publicly available datasets were analyzed in this study. This data can be found here: the Korean Genome and Epidemiology Study data are available through a procedure described at: <ext-link xlink:href="https://nih.go.kr/ko/main/main.do" ext-link-type="uri">https://nih.go.kr/ko/main/main.do</ext-link>. The Korean National Health and Nutritional Examination Survey data are available through a procedure described at: <ext-link xlink:href="https://knhanes.kdca.go.kr/knhanes/sub03/sub03_02_05.do" ext-link-type="uri">https://knhanes.kdca.go.kr/knhanes/sub03/sub03_02_05.do</ext-link>.</p>
</sec>
<sec id="sec13">
<title>Ethics statement</title>
<p>The studies involving humans were approved by IRB of Yongin Severance Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="sec14">
<title>Author contributions</title>
<p>H-MP, T-HH, J-HL, and Y-JK: study concept and design, acquisition, analysis, interpretation of data, drafting the manuscript, and approval of the final manuscript and had the final responsibility to submit the study for publication. J-HL and Y-JK: study concept and design, interpretation of data, supervision, and revising the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="funding-information" id="sec15">
<title>Funding</title>
<p>This research was financially supported by the Ministry of SMEs and Startups and Korea Technology and Promotion Agency for SMEs (TIPA) through the Regional Specialized Industry Development Plus Program (Grant number: S3370378).</p>
</sec>
<sec sec-type="COI-statement" id="sec16">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>Data in this study were obtained from 2021 Korea National Health and Nutrition Examination Survey (KNHANES) and the Korean Genome and Epidemiology Study (4851-302), the National Research Institute of Health, the Centers for Disease Control and Prevention, and the Ministry for Health and Welfare of the Republic of Korea.</p>
</ack>
<sec sec-type="supplementary-material" id="sec17">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fnut.2023.1226107/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fnut.2023.1226107/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guembe</surname><given-names>MJ</given-names></name> <name><surname>Fernandez-Lazaro</surname><given-names>CI</given-names></name> <name><surname>Sayon-Orea</surname><given-names>C</given-names></name> <name><surname>Toledo</surname><given-names>E</given-names></name> <name><surname>Moreno-Iribas</surname><given-names>C</given-names></name></person-group>. <article-title>Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort</article-title>. <source>Cardiovasc Diabetol</source>. (<year>2020</year>) <volume>19</volume>:<fpage>195</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12933-020-01166-6</pub-id>, PMID: <pub-id pub-id-type="pmid">33222691</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saklayen</surname><given-names>MG</given-names></name></person-group>. <article-title>The global epidemic of the metabolic syndrome</article-title>. <source>Curr Hypertens Rep</source>. (<year>2018</year>) <volume>20</volume>:<fpage>12</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s11906-018-0812-z</pub-id>, PMID: <pub-id pub-id-type="pmid">29480368</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nianogo</surname><given-names>RA</given-names></name> <name><surname>Arah</surname><given-names>OA</given-names></name></person-group>. <article-title>Forecasting obesity and type 2 diabetes incidence and burden: the ViLA-obesity simulation model</article-title>. <source>Front Public Health</source>. (<year>2022</year>) <volume>10</volume>:<fpage>818816</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2022.818816</pub-id>, PMID: <pub-id pub-id-type="pmid">35450123</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noubiap</surname><given-names>JJ</given-names></name> <name><surname>Nansseu</surname><given-names>JR</given-names></name> <name><surname>Lontchi-Yimagou</surname><given-names>E</given-names></name> <name><surname>Nkeck</surname><given-names>JR</given-names></name> <name><surname>Nyaga</surname><given-names>UF</given-names></name> <name><surname>Ngouo</surname><given-names>AT</given-names></name> <etal/></person-group>. <article-title>Geographic distribution of metabolic syndrome and its components in the general adult population: a meta-analysis of global data from 28 million individuals</article-title>. <source>Diabetes Res Clin Pract</source>. (<year>2022</year>) <volume>188</volume>:<fpage>109924</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.diabres.2022.109924</pub-id>, PMID: <pub-id pub-id-type="pmid">35584716</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname><given-names>JH</given-names></name> <name><surname>Kang</surname><given-names>DR</given-names></name> <name><surname>Kim</surname><given-names>JY</given-names></name> <name><surname>Koh</surname><given-names>KK</given-names></name></person-group>. <article-title>Metabolic syndrome fact sheet 2021: executive report</article-title>. <source>CardioMetabolic Syndr J</source>. (<year>2021</year>) <volume>1</volume>:<fpage>125</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.51789/cmsj.2021.1.e15</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boudreau</surname><given-names>DM</given-names></name> <name><surname>Malone</surname><given-names>DC</given-names></name> <name><surname>Raebel</surname><given-names>MA</given-names></name> <name><surname>Fishman</surname><given-names>PA</given-names></name> <name><surname>Nichols</surname><given-names>GA</given-names></name> <name><surname>Feldstein</surname><given-names>AC</given-names></name> <etal/></person-group>. <article-title>Health care utilization and costs by metabolic syndrome risk factors</article-title>. <source>Metab Syndr Relat Disord</source>. (<year>2009</year>) <volume>7</volume>:<fpage>305</fpage>&#x2013;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1089/met.2008.0070</pub-id>, PMID: <pub-id pub-id-type="pmid">19558267</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mottillo</surname><given-names>S</given-names></name> <name><surname>Filion</surname><given-names>KB</given-names></name> <name><surname>Genest</surname><given-names>J</given-names></name> <name><surname>Joseph</surname><given-names>L</given-names></name> <name><surname>Pilote</surname><given-names>L</given-names></name> <name><surname>Poirier</surname><given-names>P</given-names></name> <etal/></person-group>. <article-title>The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis</article-title>. <source>J Am Coll Cardiol</source>. (<year>2010</year>) <volume>56</volume>:<fpage>1113</fpage>&#x2013;<lpage>32</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacc.2010.05.034</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kopp</surname><given-names>HP</given-names></name> <name><surname>Kopp</surname><given-names>CW</given-names></name> <name><surname>Festa</surname><given-names>A</given-names></name> <name><surname>Krzyzanowska</surname><given-names>K</given-names></name> <name><surname>Kriwanek</surname><given-names>S</given-names></name> <name><surname>Minar</surname><given-names>E</given-names></name> <etal/></person-group>. <article-title>Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. (<year>2003</year>) <volume>23</volume>:<fpage>1042</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.Atv.0000073313.16135.21</pub-id>, PMID: <pub-id pub-id-type="pmid">12714437</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group>. <article-title>Inflammation and metabolic disorders</article-title>. <source>Nature</source>. (<year>2006</year>) <volume>444</volume>:<fpage>860</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature05485</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monserrat-Mesquida</surname><given-names>M</given-names></name> <name><surname>Quetglas-Llabr&#x00E9;s</surname><given-names>M</given-names></name> <name><surname>Cap&#x00F3;</surname><given-names>X</given-names></name> <name><surname>Bouzas</surname><given-names>C</given-names></name> <name><surname>Mateos</surname><given-names>D</given-names></name> <name><surname>Pons</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Metabolic syndrome is associated with oxidative stress and proinflammatory state</article-title>. <source>Antioxidants</source>. (<year>2020</year>) <volume>9</volume>:<fpage>236</fpage>. doi: <pub-id pub-id-type="doi">10.3390/antiox9030236</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>MA</given-names></name> <name><surname>Subhan</surname><given-names>N</given-names></name> <name><surname>Rahman</surname><given-names>MM</given-names></name> <name><surname>Uddin</surname><given-names>SJ</given-names></name> <name><surname>Reza</surname><given-names>HM</given-names></name> <name><surname>Sarker</surname><given-names>SD</given-names></name></person-group>. <article-title>Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action</article-title>. <source>Adv Nutr</source>. (<year>2014</year>) <volume>5</volume>:<fpage>404</fpage>&#x2013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.3945/an.113.005603</pub-id>, PMID: <pub-id pub-id-type="pmid">25022990</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>K</given-names></name> <name><surname>Ren</surname><given-names>M</given-names></name> <name><surname>Liu</surname><given-names>D</given-names></name> <name><surname>Wang</surname><given-names>C</given-names></name> <name><surname>Yang</surname><given-names>C</given-names></name> <name><surname>Yan</surname><given-names>L</given-names></name></person-group>. <article-title>Alcohol consumption and risk of metabolic syndrome: a meta-analysis of prospective studies</article-title>. <source>Clin Nutr</source>. (<year>2014</year>) <volume>33</volume>:<fpage>596</fpage>&#x2013;<lpage>602</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2013.10.003</pub-id>, PMID: <pub-id pub-id-type="pmid">24315622</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pradhan</surname><given-names>AD</given-names></name></person-group>. <article-title>Sex differences in the metabolic syndrome: implications for cardiovascular health in women</article-title>. <source>Clin Chem</source>. (<year>2014</year>) <volume>60</volume>:<fpage>44</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1373/clinchem.2013.202549</pub-id>, PMID: <pub-id pub-id-type="pmid">24255079</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x00E1;ndez-Ruiz</surname><given-names>&#x00C1;</given-names></name> <name><surname>Garc&#x00ED;a-Villanova</surname><given-names>B</given-names></name> <name><surname>Guerra-Hern&#x00E1;ndez</surname><given-names>E</given-names></name> <name><surname>Amiano</surname><given-names>P</given-names></name> <name><surname>Ruiz-Canela</surname><given-names>M</given-names></name> <name><surname>Molina-Montes</surname><given-names>E</given-names></name></person-group>. <article-title>A review of a priori defined oxidative balance scores relative to their components and impact on health outcomes</article-title>. <source>Nutrients</source>. (<year>2019</year>) <volume>11</volume>:<fpage>11</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu11040774</pub-id>, PMID: <pub-id pub-id-type="pmid">30987200</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>SY</given-names></name> <name><surname>Bostick</surname><given-names>RM</given-names></name> <name><surname>Flanders</surname><given-names>WD</given-names></name> <name><surname>McClellan</surname><given-names>WM</given-names></name> <name><surname>Thyagarajan</surname><given-names>B</given-names></name> <name><surname>Gross</surname><given-names>MD</given-names></name> <etal/></person-group>. <article-title>Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation</article-title>. <source>Cancer Epidemiol Biomark Prev</source>. (<year>2014</year>) <volume>23</volume>:<fpage>545</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1158/1055-9965.Epi-13-0619</pub-id>, PMID: <pub-id pub-id-type="pmid">24443405</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname><given-names>KJ</given-names></name> <name><surname>Hartman</surname><given-names>TJ</given-names></name> <name><surname>Judd</surname><given-names>SE</given-names></name> <name><surname>Ilori</surname><given-names>TO</given-names></name> <name><surname>Cheung</surname><given-names>KL</given-names></name> <name><surname>Warnock</surname><given-names>DG</given-names></name> <etal/></person-group>. <article-title>Dietary oxidative balance scores and biomarkers of inflammation among individuals with and without chronic kidney disease</article-title>. <source>Nephron Extra</source>. (<year>2018</year>) <volume>8</volume>:<fpage>11</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000490499</pub-id>, PMID: <pub-id pub-id-type="pmid">30279696</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>M</given-names></name> <name><surname>Bostick</surname><given-names>RM</given-names></name> <name><surname>Dash</surname><given-names>C</given-names></name> <name><surname>Flanders</surname><given-names>WD</given-names></name> <name><surname>Mandel</surname><given-names>JS</given-names></name></person-group>. <article-title>Hypothesis: oxidative stress score as a combined measure of pro-oxidant and antioxidant exposures</article-title>. <source>Ann Epidemiol</source>. (<year>2007</year>) <volume>17</volume>:<fpage>394</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.annepidem.2007.01.034</pub-id>, PMID: <pub-id pub-id-type="pmid">17462547</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HS</given-names></name> <name><surname>Park</surname><given-names>T</given-names></name></person-group>. <article-title>Pathway-driven approaches of interaction between oxidative balance and genetic polymorphism on metabolic syndrome</article-title>. <source>Oxidative Med Cell Longev</source>. (<year>2017</year>) <volume>2017</volume>:<fpage>6873197</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2017/6873197</pub-id>, PMID: <pub-id pub-id-type="pmid">28191276</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noruzi</surname><given-names>Z</given-names></name> <name><surname>Jayedi</surname><given-names>A</given-names></name> <name><surname>Farazi</surname><given-names>M</given-names></name> <name><surname>Asgari</surname><given-names>E</given-names></name> <name><surname>Dehghani Firouzabadi</surname><given-names>F</given-names></name> <name><surname>Akbarzadeh</surname><given-names>Z</given-names></name> <etal/></person-group>. <article-title>Association of oxidative balance score with the metabolic syndrome in a sample of Iranian adults</article-title>. <source>Oxidative Med Cell Longev</source>. (<year>2021</year>) <volume>2021</volume>:<fpage>5593919</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2021/5593919</pub-id>, PMID: <pub-id pub-id-type="pmid">34188754</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kweon</surname><given-names>S</given-names></name> <name><surname>Kim</surname><given-names>Y</given-names></name> <name><surname>Jang</surname><given-names>MJ</given-names></name> <name><surname>Kim</surname><given-names>Y</given-names></name> <name><surname>Kim</surname><given-names>K</given-names></name> <name><surname>Choi</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES)</article-title>. <source>Int J Epidemiol</source>. (<year>2014</year>) <volume>43</volume>:<fpage>69</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ije/dyt228</pub-id>, PMID: <pub-id pub-id-type="pmid">24585853</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y</given-names></name> <name><surname>Han</surname><given-names>BG</given-names></name></person-group>. <article-title>Cohort profile: the Korean Genome and Epidemiology Study (KoGES) consortium</article-title>. <source>Int J Epidemiol</source>. (<year>2017</year>) <volume>46</volume>:<fpage>e20</fpage>. doi: <pub-id pub-id-type="doi">10.1093/ije/dyv316</pub-id>, PMID: <pub-id pub-id-type="pmid">27085081</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lakkur</surname><given-names>S</given-names></name> <name><surname>Goodman</surname><given-names>M</given-names></name> <name><surname>Bostick</surname><given-names>RM</given-names></name> <name><surname>Citronberg</surname><given-names>J</given-names></name> <name><surname>McClellan</surname><given-names>W</given-names></name> <name><surname>Flanders</surname><given-names>WD</given-names></name> <etal/></person-group>. <article-title>Oxidative balance score and risk for incident prostate cancer in a prospective U.S. cohort study</article-title>. <source>Ann Epidemiol</source>. (<year>2014</year>) <volume>24</volume>:<fpage>475</fpage>&#x2013;<lpage>478.e4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.annepidem.2014.02.015</pub-id>, PMID: <pub-id pub-id-type="pmid">24731700</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>SY</given-names></name> <name><surname>Goodman</surname><given-names>M</given-names></name> <name><surname>Judd</surname><given-names>S</given-names></name> <name><surname>Bostick</surname><given-names>RM</given-names></name> <name><surname>Flanders</surname><given-names>WD</given-names></name> <name><surname>McClellan</surname><given-names>W</given-names></name></person-group>. <article-title>Oxidative balance score as predictor of all-cause, cancer, and noncancer mortality in a biracial US cohort</article-title>. <source>Ann Epidemiol</source>. (<year>2015</year>) <volume>25</volume>:<fpage>256</fpage>&#x2013;<lpage>262.e1</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.annepidem.2015.01.004</pub-id>, PMID: <pub-id pub-id-type="pmid">25682727</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>AR</given-names></name> <name><surname>Kwon</surname><given-names>YJ</given-names></name> <name><surname>Lim</surname><given-names>HJ</given-names></name> <name><surname>Lee</surname><given-names>HS</given-names></name> <name><surname>Kim</surname><given-names>S</given-names></name> <name><surname>Shim</surname><given-names>JY</given-names></name> <etal/></person-group>. <article-title>Oxidative balance score and serum &#x03B3;-glutamyltransferase level among Korean adults: a nationwide population-based study</article-title>. <source>Eur J Nutr</source>. (<year>2018</year>) <volume>57</volume>:<fpage>1237</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00394-017-1407-1</pub-id>, PMID: <pub-id pub-id-type="pmid">28258305</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puntarulo</surname><given-names>S</given-names></name></person-group>. <article-title>Iron, oxidative stress and human health</article-title>. <source>Mol Asp Med</source>. (<year>2005</year>) <volume>26</volume>:<fpage>299</fpage>&#x2013;<lpage>312</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mam.2005.07.001</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vinchi</surname><given-names>F</given-names></name> <name><surname>Muckenthaler</surname><given-names>MU</given-names></name> <name><surname>Da Silva</surname><given-names>MC</given-names></name> <name><surname>Balla</surname><given-names>G</given-names></name> <name><surname>Balla</surname><given-names>J</given-names></name> <name><surname>Jeney</surname><given-names>V</given-names></name></person-group>. <article-title>Atherogenesis and iron: from epidemiology to cellular level</article-title>. <source>Front Pharmacol</source>. (<year>2014</year>) <volume>5</volume>:<fpage>94</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2014.00094</pub-id>, PMID: <pub-id pub-id-type="pmid">24847266</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grundy</surname><given-names>SM</given-names></name> <name><surname>Cleeman</surname><given-names>JI</given-names></name> <name><surname>Daniels</surname><given-names>SR</given-names></name> <name><surname>Donato</surname><given-names>KA</given-names></name> <name><surname>Eckel</surname><given-names>RH</given-names></name> <name><surname>Franklin</surname><given-names>BA</given-names></name> <etal/></person-group>. <article-title>Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Executive summary</article-title>. <source>Cardiol Rev</source>. (<year>2005</year>) <volume>13</volume>:<fpage>322</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1097/01.crd.0000380842.14048.7e</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>MH</given-names></name> <name><surname>Lee</surname><given-names>WY</given-names></name> <name><surname>Kim</surname><given-names>SS</given-names></name> <name><surname>Kang</surname><given-names>JH</given-names></name> <name><surname>Kang</surname><given-names>JH</given-names></name> <name><surname>Kim</surname><given-names>KK</given-names></name> <etal/></person-group>. <article-title>2018 Korean Society for the Study of obesity guideline for the Management of Obesity in Korea</article-title>. <source>J Obes Metab Syndr</source>. (<year>2019</year>) <volume>28</volume>:<fpage>40</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.7570/jomes.2019.28.1.40</pub-id>, PMID: <pub-id pub-id-type="pmid">31089578</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="other"><person-group person-group-type="author"><collab id="coll101">National Research Institute of Health. Korean Genome and Epidemiology Study</collab></person-group>. (<year>2023</year>). Available at: <ext-link xlink:href="https://nih.go.kr/ko/main/contents.do?menuNo=300563" ext-link-type="uri">https://nih.go.kr/ko/main/contents.do?menuNo=300563</ext-link> (Accessed March 15, 2023).</citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sainas</surname><given-names>G</given-names></name> <name><surname>Milia</surname><given-names>R</given-names></name> <name><surname>Palazzolo</surname><given-names>G</given-names></name> <name><surname>Ibba</surname><given-names>G</given-names></name> <name><surname>Marongiu</surname><given-names>E</given-names></name> <name><surname>Roberto</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Mean blood pressure assessment during post-exercise: result from two different methods of calculation</article-title>. <source>J Sports Sci Med</source>. (<year>2016</year>) <volume>15</volume>:<fpage>424</fpage>&#x2013;<lpage>33</lpage>. PMID: <pub-id pub-id-type="pmid">27803621</pub-id></citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>JY</given-names></name> <name><surname>Yang</surname><given-names>YJ</given-names></name> <name><surname>Kim</surname><given-names>BS</given-names></name> <name><surname>Kang</surname><given-names>JH</given-names></name></person-group>. <article-title>Validity and reliability of Korean version of international physical activity questionnaire (IPAQ) short form</article-title>. <source>J Korean Acad Fam Med</source>. (<year>2007</year>) <volume>28</volume>:<fpage>532</fpage>&#x2013;<lpage>41</lpage>.</citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DW</given-names></name> <name><surname>Song</surname><given-names>S</given-names></name> <name><surname>Lee</surname><given-names>JE</given-names></name> <name><surname>Oh</surname><given-names>K</given-names></name> <name><surname>Shim</surname><given-names>J</given-names></name> <name><surname>Kweon</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Reproducibility and validity of an FFQ developed for the Korea National Health and Nutrition Examination Survey (KNHANES)</article-title>. <source>Public Health Nutr</source>. (<year>2015</year>) <volume>18</volume>:<fpage>1369</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1017/s1368980014001712</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>Y</given-names></name> <name><surname>Kwon</surname><given-names>E</given-names></name> <name><surname>Shim</surname><given-names>JE</given-names></name> <name><surname>Park</surname><given-names>MK</given-names></name> <name><surname>Joo</surname><given-names>Y</given-names></name> <name><surname>Kimm</surname><given-names>K</given-names></name> <etal/></person-group>. <article-title>Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study</article-title>. <source>Eur J Clin Nutr</source>. (<year>2007</year>) <volume>61</volume>:<fpage>1435</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.ejcn.1602657</pub-id>, PMID: <pub-id pub-id-type="pmid">17299477</pub-id></citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>YW</given-names></name> <name><surname>Zhu</surname><given-names>S</given-names></name> <name><surname>Palaniappan</surname><given-names>L</given-names></name> <name><surname>Heshka</surname><given-names>S</given-names></name> <name><surname>Carnethon</surname><given-names>MR</given-names></name> <name><surname>Heymsfield</surname><given-names>SB</given-names></name></person-group>. <article-title>The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third National Health and nutrition examination survey, 1988-1994</article-title>. <source>Arch Intern Med</source>. (<year>2003</year>) <volume>163</volume>:<fpage>427</fpage>&#x2013;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinte.163.4.427</pub-id>, PMID: <pub-id pub-id-type="pmid">12588201</pub-id></citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>FE</given-names></name> <name><surname>Zhang</surname><given-names>FL</given-names></name> <name><surname>Zhang</surname><given-names>P</given-names></name> <name><surname>Liu</surname><given-names>D</given-names></name> <name><surname>Liu</surname><given-names>HY</given-names></name> <name><surname>Guo</surname><given-names>ZN</given-names></name> <etal/></person-group>. <article-title>Sex-based differences in and risk factors for metabolic syndrome in adults aged 40 years and above in Northeast China: results from the cross-sectional China national stroke screening survey</article-title>. <source>BMJ Open</source>. (<year>2021</year>) <volume>11</volume>:<fpage>e038671</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2020-038671</pub-id>, PMID: <pub-id pub-id-type="pmid">33762227</pub-id></citation></ref>
<ref id="ref36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name></person-group>. <article-title>Multicollinearity and misleading statistical results</article-title>. <source>Korean J Anesthesiol</source>. (<year>2019</year>) <volume>72</volume>:<fpage>558</fpage>&#x2013;<lpage>69</lpage>. doi: <pub-id pub-id-type="doi">10.4097/kja.19087</pub-id>, PMID: <pub-id pub-id-type="pmid">31304696</pub-id></citation></ref>
<ref id="ref37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Annor</surname><given-names>FB</given-names></name> <name><surname>Goodman</surname><given-names>M</given-names></name> <name><surname>Okosun</surname><given-names>IS</given-names></name> <name><surname>Wilmot</surname><given-names>DW</given-names></name> <name><surname>Il'yasova</surname><given-names>D</given-names></name> <name><surname>Ndirangu</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Oxidative stress, oxidative balance score, and hypertension among a racially diverse population</article-title>. <source>J Am Soc Hypertens</source>. (<year>2015</year>) <volume>9</volume>:<fpage>592</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jash.2015.05.014</pub-id>, PMID: <pub-id pub-id-type="pmid">26160262</pub-id></citation></ref>
<ref id="ref38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sohouli</surname><given-names>MH</given-names></name> <name><surname>Rohani</surname><given-names>P</given-names></name> <name><surname>Hosseinzadeh</surname><given-names>M</given-names></name> <name><surname>Hekmatdoost</surname><given-names>A</given-names></name></person-group>. <article-title>Adherence to oxidative balance scores and lower odds of non-alcoholic fatty liver disease: a case-control study</article-title>. <source>Sci Rep</source>. (<year>2023</year>) <volume>13</volume>:<fpage>6140</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-023-33407-5</pub-id>, PMID: <pub-id pub-id-type="pmid">37061551</pub-id></citation></ref>
<ref id="ref39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Talavera-Rodriguez</surname><given-names>I</given-names></name> <name><surname>Fernandez-Lazaro</surname><given-names>CI</given-names></name> <name><surname>Hern&#x00E1;ndez-Ruiz</surname><given-names>&#x00C1;</given-names></name> <name><surname>Hershey</surname><given-names>MS</given-names></name> <name><surname>Galarregui</surname><given-names>C</given-names></name> <name><surname>Sotos-Prieto</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Association between an oxidative balance score and mortality: a prospective analysis in the SUN cohort</article-title>. <source>Eur J Nutr</source>. (<year>2023</year>) <volume>62</volume>:<fpage>1667</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00394-023-03099-8</pub-id>, PMID: <pub-id pub-id-type="pmid">36781422</pub-id></citation></ref>
<ref id="ref40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korsager Larsen</surname><given-names>M</given-names></name> <name><surname>Matchkov</surname><given-names>VV</given-names></name></person-group>. <article-title>Hypertension and physical exercise: the role of oxidative stress</article-title>. <source>Medicina</source>. (<year>2016</year>) <volume>52</volume>:<fpage>19</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.medici.2016.01.005</pub-id></citation></ref>
<ref id="ref41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castro-Barquero</surname><given-names>S</given-names></name> <name><surname>Ruiz-Le&#x00F3;n</surname><given-names>AM</given-names></name> <name><surname>Sierra-P&#x00E9;rez</surname><given-names>M</given-names></name> <name><surname>Estruch</surname><given-names>R</given-names></name> <name><surname>Casas</surname><given-names>R</given-names></name></person-group>. <article-title>Dietary strategies for metabolic syndrome: a comprehensive review</article-title>. <source>Nutrients</source>. (<year>2020</year>) <volume>12</volume>:<fpage>12</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu12102983</pub-id>, PMID: <pub-id pub-id-type="pmid">33003472</pub-id></citation></ref>
<ref id="ref42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vozarova</surname><given-names>B</given-names></name> <name><surname>Weyer</surname><given-names>C</given-names></name> <name><surname>Lindsay</surname><given-names>RS</given-names></name> <name><surname>Pratley</surname><given-names>RE</given-names></name> <name><surname>Bogardus</surname><given-names>C</given-names></name> <name><surname>Tataranni</surname><given-names>PA</given-names></name></person-group>. <article-title>High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes</article-title>. <source>Diabetes</source>. (<year>2002</year>) <volume>51</volume>:<fpage>455</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.2337/diabetes.51.2.455</pub-id></citation></ref>
<ref id="ref43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>YC</given-names></name> <name><surname>Woollard</surname><given-names>KJ</given-names></name> <name><surname>McClelland</surname><given-names>RL</given-names></name> <name><surname>Allison</surname><given-names>MA</given-names></name> <name><surname>Rye</surname><given-names>KA</given-names></name> <name><surname>Ong</surname><given-names>KL</given-names></name> <etal/></person-group>. <article-title>The association of plasma lipids with white blood cell counts: results from the multi-ethnic study of atherosclerosis</article-title>. <source>J Clin Lipidol</source>. (<year>2019</year>) <volume>13</volume>:<fpage>812</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacl.2019.07.003</pub-id>, PMID: <pub-id pub-id-type="pmid">31402296</pub-id></citation></ref>
<ref id="ref44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Babio</surname><given-names>N</given-names></name> <name><surname>Ibarrola-Jurado</surname><given-names>N</given-names></name> <name><surname>Bull&#x00F3;</surname><given-names>M</given-names></name> <name><surname>Mart&#x00ED;nez-Gonz&#x00E1;lez</surname><given-names>M</given-names></name> <name><surname>W&#x00E4;rnberg</surname><given-names>J</given-names></name> <name><surname>Salaverr&#x00ED;a</surname><given-names>I</given-names></name> <etal/></person-group>. <article-title>White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study</article-title>. <source>PLoS One</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e58354</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0058354</pub-id>, PMID: <pub-id pub-id-type="pmid">23526980</pub-id></citation></ref>
<ref id="ref45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shiraseb</surname><given-names>F</given-names></name> <name><surname>Ebrahimi</surname><given-names>S</given-names></name> <name><surname>Noori</surname><given-names>S</given-names></name> <name><surname>Bagheri</surname><given-names>R</given-names></name> <name><surname>Alvarez-Alvarado</surname><given-names>S</given-names></name> <name><surname>Wong</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>The association between diet quality index-international and inflammatory markers in Iranian overweight and obese women</article-title>. <source>Front Nutr</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1164281</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2023.1164281</pub-id>, PMID: <pub-id pub-id-type="pmid">37275644</pub-id></citation></ref>
<ref id="ref46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>LS</given-names></name> <name><surname>Gerszten</surname><given-names>RE</given-names></name> <name><surname>Taylor</surname><given-names>JM</given-names></name> <name><surname>Pedersen</surname><given-names>BK</given-names></name> <name><surname>van Praag</surname><given-names>H</given-names></name> <name><surname>Trappe</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Exerkines in health, resilience and disease</article-title>. <source>Nat Rev Endocrinol</source>. (<year>2022</year>) <volume>18</volume>:<fpage>273</fpage>&#x2013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41574-022-00641-2</pub-id>, PMID: <pub-id pub-id-type="pmid">35304603</pub-id></citation></ref>
<ref id="ref47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>HC</given-names></name> <name><surname>Duncan</surname><given-names>BB</given-names></name> <name><surname>Schmidt</surname><given-names>MI</given-names></name> <name><surname>Wang</surname><given-names>NY</given-names></name> <name><surname>Brancati</surname><given-names>FL</given-names></name></person-group>. <article-title>Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study</article-title>. <source>Ann Intern Med</source>. (<year>2010</year>) <volume>152</volume>:<fpage>10</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.7326/0003-4819-152-1-201001050-00005</pub-id>, PMID: <pub-id pub-id-type="pmid">20048267</pub-id></citation></ref>
<ref id="ref48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarparanta</surname><given-names>J</given-names></name> <name><surname>Garc&#x00ED;a-Macia</surname><given-names>M</given-names></name> <name><surname>Singh</surname><given-names>R</given-names></name></person-group>. <article-title>Autophagy and mitochondria in obesity and type 2 diabetes</article-title>. <source>Curr Diabetes Rev</source>. (<year>2017</year>) <volume>13</volume>:<fpage>352</fpage>&#x2013;<lpage>69</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1573399812666160217122530</pub-id></citation></ref>
<ref id="ref49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Resnicow</surname><given-names>K</given-names></name> <name><surname>Odom</surname><given-names>E</given-names></name> <name><surname>Wang</surname><given-names>T</given-names></name> <name><surname>Dudley</surname><given-names>WN</given-names></name> <name><surname>Mitchell</surname><given-names>D</given-names></name> <name><surname>Vaughan</surname><given-names>R</given-names></name> <etal/></person-group>. <article-title>Validation of three food frequency questionnaires and 24-hour recalls with serum carotenoid levels in a sample of African-American adults</article-title>. <source>Am J Epidemiol</source>. (<year>2000</year>) <volume>152</volume>:<fpage>1072</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1093/aje/152.11.1072</pub-id></citation></ref>
</ref-list>
</back>
</article>